Suzanne Oparil

Q: What Schools Are Affiliated With Suzanne Oparil

Suzanne Oparil is affiliated with the following schools: University of Alabama, University of Alberta, Shihezi University, McMaster University, University of Tennessee, University of Notre Dame, Cornell University, Yangzhou University, Columbia University, Massachusetts General Hospital, New York University, Tulane University, University of Bergen, University of Minnesota, University of Washington, Rush University, University of Alabama at Birmingham

Suzanne Oparil's AcademicInfluence.com Rankings

Suzanne Oparil

Biology

#2294

World Rank

#3659

Historical Rank

Physiology

#39

World Rank

#132

Historical Rank

biology Degrees

Download Badge

Biology

Suzanne Oparil's Degrees

PhD Physiology University of Alabama
Doctorate Medicine University of Alabama

Why Is Suzanne Oparil Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Suzanne Oparil is a clinical cardiologist and Distinguished Professor of Medicine, Professor of Cell, Developmental, and Integrative Biology. She is the Section Chief of Vascular Biology and Hypertension and the Director of the Vascular Biology and Hypertension Program of the Division of Cardiovascular Disease at the University of Alabama-Birmingham Medical School.

(See a Problem?)

Suzanne Oparil's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. (2003) (25415)
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. (2003) (15453)
2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). (2014) (6976)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol (2002) (5504)
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). (2002) (5253)
A Randomized Trial of Intensive versus Standard Blood-Pressure Control. (2016) (3162)
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. (1997) (2803)
A controlled trial of renal denervation for resistant hypertension. (2014) (1851)
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. (2011) (1730)
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol (2002) (1631)
Evidence-Based Guideline for the Management of High Blood Pressure in Adults (2012) (1417)
Essential hypertension. Part I: definition and etiology. (2000) (1133)
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial. (2016) (924)
Physical activity and cardiovascular health. (1996) (913)
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. (2011) (895)
Feasibility of treating prehypertension with an angiotensin-receptor blocker. (2006) (894)
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. (2011) (888)
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. (2007) (873)
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women (2004) (788)
Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention (2007) (783)
Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial (2019) (639)
Kidney disease: Improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease (2012) (637)
Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study (2005) (603)
Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study (2003) (598)
Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (1996) (573)
Perioperative red blood cell transfusion (1988) (569)
Sex hormones and hypertension. (2002) (498)
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women (2004) (492)
Effects of Dietary Sodium Reduction on Blood Pressure in Subjects With Resistant Hypertension: Results From a Randomized Trial (2009) (483)
Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. (2015) (477)
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. (2002) (469)
Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial (2007) (444)
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (2002) (416)
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial (2018) (413)
The Relationship Between Visit-to-Visit Variability in Systolic Blood Pressure and All-Cause Mortality in the General Population: Findings From NHANES III, 1988 to 1994 (2011) (409)
Drugs targeting the renin–angiotensin–aldosterone system (2002) (406)
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT) (2014) (398)
Pathogenesis of Hypertension (2003) (370)
Guide to Preventive Cardiology for Women (1999) (362)
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. (1997) (356)
Effects of Intensive BP Control in CKD. (2017) (320)
Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. (1995) (310)
Catheter‐Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN‐3 Trial (2012) (306)
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. (1998) (302)
Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. (2000) (288)
Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion. (2008) (280)
Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. (1994) (279)
Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. (1996) (279)
The renin-angiotensin system (first of two parts). (1974) (266)
Comparative Efficacy of Olmesartan, Losartan, Valsartan, and Irbesartan in the Control of Essential Hypertension (2001) (265)
Spironolactone Reduces Severity of Obstructive Sleep Apnea in Patients with Resistant Hypertension: a Preliminary Report (2009) (263)
Dietary changes favorably affect bone remodeling in older adults. (1999) (251)
Neuronal and Adrenomedullary Catecholamine Release in Response to Cardiopulmonary Bypass in Man (1982) (245)
Evidence-based guidelines for cardiovascular disease prevention in women. (2004) (243)
Estrogen and mechanisms of vascular protection. (2009) (242)
Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. (1992) (241)
Effects of increased consumption of fluid milk on energy and nutrient intake, body weight, and cardiovascular risk factors in healthy older adults. (2000) (230)
Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations. (1997) (226)
A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients: impact on cardiovascular risk reduction. (2000) (223)
Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients. (2003) (223)
Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality (2015) (220)
Role of the renal sympathetic nerves in the development and maintenance of hypertension in the spontaneously hypertensive rat. (1980) (220)
Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. (2015) (216)
Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions. (2019) (207)
Atrial Natriuretic Peptide Inhibits Transforming Growth Factor β–Induced Smad Signaling and Myofibroblast Transformation in Mouse Cardiac Fibroblasts (2008) (204)
Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces. (1997) (203)
New approaches in the treatment of hypertension. (2015) (201)
Less-tight versus tight control of hypertension in pregnancy. (2015) (195)
Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process. (2004) (194)
Normobaric hypoxia stimulates endothelin-1 gene expression in the rat. (1992) (192)
Importance of Renal Sympathetic Tone in the Development of DOCA‐Salt Hypertension in the Rat (1980) (191)
Diurnal patterns and regulation of cortisol secretion in pregnancy. (1980) (189)
Refractory Hypertension: Definition, Prevalence, and Patient Characteristics (2012) (187)
ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat. (1995) (185)
Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. (2014) (182)
Pathogenesis of paroxysmal hypertension developing during and after coronary bypass surgery: a study of hemodynamic and humoral factors. (1980) (179)
Effects of Pressure Overload on Extracellular Matrix Expression in the Heart of the Atrial Natriuretic Peptide–Null Mouse (2003) (175)
Refractory Hypertension: Determination of Prevalence, Risk Factors, and Comorbidities in a Large, Population-Based Cohort (2014) (172)
Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial) (2018) (170)
Salt Sensitivity, a Determinant of Blood Pressure, Cardiovascular Disease and Survival (2006) (168)
Estrogen Modulates Inflammatory Mediator Expression and Neutrophil Chemotaxis in Injured Arteries (2004) (165)
The National Health and Nutrition Examination Survey III (2001) (163)
H35: Baseline characteristics of the life (Losartan intervention for endpoint reduction) in hypertension study (1997) (161)
Treatment of hypertensive crisis. (1990) (161)
Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. (2010) (154)
Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system. (2009) (153)
Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study. (2010) (152)
Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review. (2020) (150)
The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension. (1996) (148)
Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat. (1995) (145)
Rapid Reversal of Left Ventricular Hypertrophy and Intracardiac Volume Overload in Patients With Resistant Hypertension and Hyperaldosteronism: A Prospective Clinical Study (2010) (144)
Myocardial cell hypertrophy or hyperplasia. (1984) (139)
Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy (2004) (139)
AHA/ACC scientific statement: consensus panel statement. Guide to preventive cardiology for women. American Heart Association/American College of Cardiology. (1999) (138)
Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery. (1996) (137)
Estrogen-induced vasoprotection is estrogen receptor dependent: evidence from the balloon-injured rat carotid artery model. (2000) (136)
Renal tubular transport and catabolism of proteins and peptides. (1979) (136)
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. (1996) (136)
Increased endothelin receptor gene expression in hypoxic rat lung. (1994) (134)
Isolation of two distinct type I angiotensin II receptor genes. (1992) (134)
Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension (2015) (132)
Normotensive blacks have heightened sympathetic response to cold pressor test. (1993) (130)
The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats. (1997) (128)
Atrial Natriuretic Factor Prevents NaCl‐Sensitive Hypertension in Spontaneously Hypertensive Rats (1990) (125)
Effect of Intensive Blood‐Pressure Treatment on Patient‐Reported Outcomes (2017) (123)
Prevalence of apparent treatment-resistant hypertension among individuals with CKD. (2013) (122)
Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension. (2000) (122)
Decrease in peripheral sympathetic nervous system activity following renal denervation or unclipping in the one-kidney one-clip Goldblatt hypertensive rat. (1982) (118)
Role of Renin in Acute Postural Homeostasis (1970) (117)
Guide to Preventive Cardiology for Women.AHA/ACC Scientific Statement Consensus panel statement. (1999) (117)
Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment. (1997) (114)
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. (2021) (112)
Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality. (2014) (110)
The renin-angiotensin system (second of two parts). (1974) (110)
Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells. (2004) (110)
Nutritional management of cardiovascular risk factors. A randomized clinical trial. (1997) (110)
Hypertension in women. (1999) (110)
Role of the Renal Nerves in the Pathogenesis of One‐Kidney Renal Hypertension in the Rat (1981) (109)
Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute. (2008) (108)
Salt intake and plasma atrial natriuretic peptide and nitric oxide in hypertension. (1996) (107)
Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs. (1997) (107)
Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation. (1995) (106)
Estrogen modulates TNF-α-induced inflammatory responses in rat aortic smooth muscle cells through estrogen receptor-β activation (2007) (105)
Effect of Intensive Versus Standard Blood Pressure Lowering on Diastolic Function in Patients With Uncontrolled Hypertension and Diastolic Dysfunction (2010) (105)
Development of Left Ventricular Hypertrophy in Young Spontaneously Hypertensive Rats after Peripheral Sympathectomy (1977) (104)
Hormones and Vasoprotection (1999) (104)
12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial. (2015) (104)
Adherence and persistence with taking medication to control high blood pressure. (2011) (103)
In‐Vivo and In‐Vitro Conversion of Angiotensin I to Angiotensin II in Dog Blood (1970) (103)
Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report (2014) (103)
Estradiol and Progestins Differentially Modulate Leukocyte Infiltration After Vascular Injury (2004) (101)
Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol: The Losartan Intervention For Endpoint Reduction in Hypertension Study (2005) (100)
VEGF nanoparticles repair the heart after myocardial infarction. (2018) (100)
High NaCl diet reduces hypothalamic norepinephrine turnover in hypertensive rats. (1988) (100)
Myocardial hypertrophy and ventricular performance in the absence of hypertension in spontaneously hypertensive rats. (1978) (99)
A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension. (1999) (99)
Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension (2015) (98)
Estrogen restores endothelial cell function in an experimental model of vascular injury. (1997) (98)
Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling. (2006) (97)
Gender and Blood Pressure (2005) (96)
Diurnal blood pressure variation and dietary salt in spontaneously hypertensive rats. (1994) (96)
SPRINT Trial Results: Latest News in Hypertension Management. (2016) (95)
Transforming growth factor-beta signaling mediates hypoxia-induced pulmonary arterial remodeling and inhibition of alveolar development in newborn mouse lung. (2008) (95)
Phosphatidylinositol-3-kinase signaling mediates vascular smooth muscle cell expression of periostin in vivo and in vitro. (2006) (95)
O-GlcNAc Modification of NFκB p65 Inhibits TNF-α-Induced Inflammatory Mediator Expression in Rat Aortic Smooth Muscle Cells (2011) (94)
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial (2021) (93)
Association of Clinical and Social Factors With Excess Hypertension Risk in Black Compared With White US Adults (2018) (93)
Effects of ACE Inhibitors, Calcium Antagonists, and Other Blood Pressure lowering Drugs (2001) (93)
Endothelin and pulmonary hypertension. (2000) (92)
Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury. (2008) (90)
Prehypertension: epidemiology, consequences and treatment (2010) (90)
Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene. (2002) (90)
Reproducibility of visit-to-visit variability of blood pressure measured as part of routine clinical care (2011) (89)
Estrogen Modulates NFκB Signaling by Enhancing IκBα Levels and Blocking p65 Binding at the Promoters of Inflammatory Genes via Estrogen Receptor-β (2012) (89)
Sodium-neural interactions in the development of spontaneous hypertension. (1982) (86)
Inhibition of transforming growth factor-beta signaling induces left ventricular dilation and dysfunction in the pressure-overloaded heart. (2010) (86)
Importance of the Renal Nerves in Established Two‐Kidney, One Clip Goldblatt Hypertension (1982) (86)
Altered vascular reactivity and baroreflex sensitivity induced by chronic central administration of captopril in the spontaneously hypertensive rat. (1983) (86)
Newly emerging pharmacologic differences in angiotensin II receptor blockers. (2000) (86)
Desoxycorticosterone in normal pregnancy. I. Sequential studies of the secretory patterns of desoxycorticosterone, aldosterone, and cortisol. (1978) (85)
Estrogen attenuates the adventitial contribution to neointima formation in injured rat carotid arteries. (1999) (85)
Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension. (1996) (85)
Dietary compliance and cardiovascular risk reduction with a prepared meal plan compared with a self-selected diet. (1997) (85)
Trends in Hypertension Prevalence, Awareness, Treatment, and Control Among US Adults 80 Years and Older, 1988–2010 (2014) (83)
Comparison of Increasing Doses of Olmesartan Medoxomil, Losartan Potassium, and Valsartan in Patients With Essential Hypertension (2007) (83)
Effect of progesterone on renal sodium handling in man: relation to aldosterone excretion and plasma renin activity. (1975) (82)
ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. (2009) (82)
Importance of the renal nerves in established two-kidney, one clip Goldblatt hypertension. (1982) (81)
Micropuncture evidence of rapid hydrolysis of bradykinin by rat proximal tubule. (1976) (81)
Prevalence and Correlates of Low Medication Adherence in Apparent Treatment‐Resistant Hypertension (2012) (80)
Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo. (1999) (79)
Low sodium intake--cardiovascular health benefit or risk? (2014) (78)
Hormone replacement therapy and inflammation: interactions in cardiovascular disease. (2003) (78)
Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial (2017) (77)
The sympathetic nervous system in clinical and experimental hypertension. (1986) (77)
Relation of Dietary Salt and Aldosterone to Urinary Protein Excretion in Subjects With Resistant Hypertension (2008) (77)
Hypertension in women (2000) (77)
Refractory Hypertension: Evidence of Heightened Sympathetic Activity as a Cause of Antihypertensive Treatment Failure. (2015) (77)
Association Between Antihypertensive Medication Adherence and Visit‐to‐Visit Variability of Blood Pressure (2013) (75)
Essential hypertension : part II: treatment. (2000) (75)
A Progress Report on Hypertension (1981) (75)
Effects of Losartan or Atenolol in Hypertensive Patients without Clinically Evident Vascular Disease: A Substudy of the LIFE Randomized Trial (2003) (75)
Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse. (2004) (75)
Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension. (1999) (74)
Relationships between metrics of visit-to-visit variability of blood pressure (2013) (74)
Garlic prevents hypoxic pulmonary hypertension in rats. (1998) (73)
Pressor effect of blocking atrial natriuretic peptide in nucleus tractus solitarii. (1992) (73)
Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension (2009) (73)
The renal afferent nerves in the pathogenesis of hypertension. (1987) (72)
Clinical Significance of Incident Hypokalemia and Hyperkalemia in Treated Hypertensive Patients in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (2012) (72)
The technical report on sodium intake and cardiovascular disease in low- and middle-income countries by the joint working group of the World Heart Federation, the European Society of Hypertension and the European Public Health Association. (2017) (72)
Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR. (2012) (72)
Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension. (2003) (72)
An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study Investigators. (1998) (72)
Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Fenoldopam Study Group. (2008) (72)
Hypertension produced by a high sodium diet in the borderline hypertensive rat (BHR). (1987) (72)
Regional Myocyte Size in Normotensive and Spontaneously Hypertensive Rats (1979) (70)
Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia. (1990) (70)
Cost‐Effectiveness of Intensive versus Standard Blood‐Pressure Control (2017) (70)
Long-Term Effects of Incident Diabetes Mellitus on Cardiovascular Outcomes in People Treated for Hypertension: The ALLHAT Diabetes Extension Study (2012) (70)
Pathogenesis of ventricular hypertrophy. (1985) (69)
Loss of Thy-1 inhibits alveolar development in the newborn mouse lung. (2009) (69)
Management of hypertension in the elderly (2012) (68)
Atrial Natriuretic Peptide Dose-Dependently Inhibits Pressure Overload–Induced Cardiac Remodeling (2004) (67)
Endothelial dysfunction in the pulmonary vascular bed. (2000) (67)
Endothelin-A Receptor Blockade Prevents and Partially Reverses Neonatal Hypoxic Pulmonary Vascular Remodeling (2005) (67)
Multicenter randomized trial of a comprehensive prepared meal program in type 2 diabetes. (1999) (67)
Estrogen inhibits vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro. (1999) (67)
Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators. (1998) (67)
Accuracy of Blood Pressure Measurement Devices in Pregnancy: A Systematic Review of Validation Studies (2018) (67)
Blood Pressure Measurement Device, Number and Timing of Visits, and Intra‐Individual Visit‐to‐Visit Variability of Blood Pressure (2012) (66)
Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake. (2020) (65)
Factors affecting blood pressure responses to diet: the Vanguard study. (2000) (65)
Effects of short-term estrogen treatment on the neointimal response to balloon injury of rat carotid artery. (2000) (65)
Neuronal control of the kidney: contribution to hypertension. (1992) (65)
Treatment of Resistant and Refractory Hypertension. (2019) (65)
The role of calcium in the control of renin release. (1982) (63)
Clinical Expert Consensus Documents A Report of the American College of Cardiology Foundation Task Force on ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly: (2011) (63)
Estrogen depletion induces NaCl-sensitive hypertension in female spontaneously hypertensive rats. (2001) (63)
Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT (2018) (62)
Hypoxia induces downregulation of PPAR-γ in isolated pulmonary arterial smooth muscle cells and in rat lung via transforming growth factor-β signaling. (2011) (62)
Role of angiotensin receptor blockers as monotherapy in reaching blood pressure goals. (2005) (62)
Attenuation of the development of spontaneous hypertension in rats by chronic central administration of captopril. (1983) (62)
ANP signaling inhibits TGF-beta-induced Smad2 and Smad3 nuclear translocation and extracellular matrix expression in rat pulmonary arterial smooth muscle cells. (2007) (62)
Sensory denervation of the kidney attenuates renovascular hypertension in the rat. (1986) (62)
Efficacy and Safety of Long‐Term Treatment With the Combination of Amlodipine Besylate and Olmesartan Medoxomil in Patients With Hypertension (2009) (62)
Treatment for Mild Chronic Hypertension during Pregnancy. (2022) (61)
Cardiovascular effects of estrogen. (2001) (61)
Estrogen attenuates integrin-beta(3)-dependent adventitial fibroblast migration after inhibition of osteopontin production in vascular smooth muscle cells. (2000) (60)
Sensitive method for quantitation of angiotensin-converting enzyme (ACE) activity in tissue. (1995) (60)
Efficacy and Safety of Irbesartan/HCTZ Combination Therapy As Initial Treatment for Rapid Control of Severe Hypertension (2006) (60)
Blood pressures and cardiovascular homeostasis in mice having reduced or absent angiotensin-converting enzyme gene function. (1997) (60)
Sleep apnea, aldosterone, and resistant hypertension. (2009) (60)
Hypertension: A Companion to Brenner and Rector's The Kidney (2005) (59)
An assessment of diltiazem and hydrochlorothiazide in hypertension. Application of factorial trial design to a multicenter clinical trial of combination therapy. (1990) (59)
Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension　- Insights From the SYMPLICITY HTN-3 Trial. (2016) (58)
Aged rats lose vasoprotective and anti-inflammatory actions of estrogen in injured arteries (2007) (58)
Mechanisms and treatment of resistant hypertension. (2007) (58)
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. (2004) (58)
Exaggerated neointima formation in human C-reactive protein transgenic mice is IgG Fc receptor type I (Fc gamma RI)-dependent. (2008) (58)
Rationale, Design, and Methods (1997) (58)
Incidence and Predictors of Angioedema in Elderly Hypertensive Patients at High Risk for Cardiovascular Disease: A Report From the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (2006) (58)
Sympathetic function in spontaneously hypertensive rats after chronic administration of captopril. (1987) (57)
Is Blood Pressure Control for Stroke Prevention the Correct Goal?: The Lost Opportunity of Preventing Hypertension (2015) (57)
Fibroblast Growth Factor Receptor-1 Signaling Induces Osteopontin Expression and Vascular Smooth Muscle Cell–Dependent Adventitial Fibroblast Migration In Vitro (2002) (57)
Pressure‐independent enhancement of cardiac hypertrophy in atrial natriuretic peptide–deficient mice (2003) (56)
Acute O-GlcNAcylation prevents inflammation-induced vascular dysfunction. (2012) (56)
Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg (2017) (56)
Managing the patient with hard-to-control hypertension. (1998) (56)
The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. (2016) (56)
Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat. (1986) (55)
Hypertension in Women: Recent Advances and Lingering Questions (2017) (55)
Nontraditional cardiovascular risk factors. (1999) (55)
Hypoxia stimulates endothelial cell angiotensin-converting enzyme antigen synthesis. (1989) (55)
Mechanism of Pulmonary Conversion of Anglotensin II to Angiotensin II in the Dog (1971) (54)
Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease. (1999) (54)
Estrogen-Induced Vasoprotection Is Independent of Inducible Nitric Oxide Synthase Expression: Evidence From the Mouse Carotid Artery Ligation Model (2001) (54)
Spontaneously hypertensive rats exhibit reduced hypothalamic noradrenergic input after NaCl loading. (1987) (54)
Women and Hypertension: What Did We Learn from the Women’s Health Initiative? (2006) (54)
Fenoldopam: a new parenteral antihypertensive: consensus roundtable on the management of perioperative hypertension and hypertensive crises. (1999) (54)
Effects of Losartan in Women With Hypertension and Left Ventricular Hypertrophy: Results From the Losartan Intervention For Endpoint Reduction in Hypertension Study (2008) (54)
Effect of Chlorthalidone, Amlodipine, and Lisinopril on Visit‐to‐Visit Variability of Blood Pressure: Results From the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (2014) (53)
The neural basis of salt sensitivity in the rat: altered hypothalamic function. (1988) (53)
Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement. (2016) (52)
Hypertensive Therapy: Part II (2004) (52)
De novo intrarenal formation of angiotensin II during control and enhanced renin secretion. (1987) (52)
Long-Term Follow-Up of Participants With Heart Failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (2011) (52)
Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism. (2013) (52)
Gender and dietary NaCl in spontaneously hypertensive and Wistar-Kyoto rats. (1995) (52)
Depressor effect of blocking angiotensin subtype 1 receptors in anterior hypothalamus. (1992) (51)
Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT). (2017) (51)
Estrogen modulates TNF-alpha-induced inflammatory responses in rat aortic smooth muscle cells through estrogen receptor-beta activation. (2007) (51)
Purification of an angiotensin II binding protein by using antibodies to a peptide encoded by angiotensin II complementary RNA. (1988) (51)
Fixed-Dose Combinations in the Management of Hypertension (2005) (50)
Major clinical trials of hypertension: what should be done next? (2005) (50)
Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults: Secondary Analysis of a Randomized Clinical Trial (2017) (50)
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): Practical Implications (2003) (50)
Effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiency. (2013) (49)
Desoxycorticosterone in normal pregnancy (1978) (49)
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint. (2000) (49)
Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure (2016) (48)
Estrogen Effects on Vascular Inflammation Are Age Dependent: Role of Estrogen Receptors (2014) (48)
2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (2018) (48)
Decreased serum angiotensin converting enzyme in adult respiratory distress syndrome associated with sepsis: A preliminary report (1981) (48)
The Antihypertensive Effect of Lisinopril Compared to Atenolol in Patients with Mild to Moderate Hypertension (1987) (48)
Treatment of hypertension by computer and physician-a prospective controlled study. (1977) (47)
Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat. (1999) (47)
Role of oxygen availability in CFTR expression and function. (2008) (47)
Inhibition of renin release from rat kidney slices by the angiotensins. (1978) (47)
Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone. (2011) (47)
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors (2009) (47)
The contributions of unhealthy lifestyle factors to apparent resistant hypertension: findings from the Reasons for Geographic And Racial Differences in Stroke (REGARDS) study (2013) (47)
Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study. (2014) (46)
Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease (2012) (46)
Blocking hypothalamic AT1 receptors lowers blood pressure in salt-sensitive rats. (1992) (46)
Report of the task force on children and youth. American Heart Association. (1993) (46)
Decrease in Hypothalamic Norepinephrine Content Following Renal Denervation in the One‐Kidney, One Clip Goldblatt Hypertensive Rat (1982) (46)
Orthostatic changes in systolic blood pressure among SPRINT participants at baseline. (2016) (45)
Role of Matrix Metalloproteinase-2 in Newborn Mouse Lungs under Hypoxic Conditions (2008) (45)
Nutritionally complete prepared meal plan to reduce cardiovascular risk factors: a randomized clinical trial. (1999) (44)
Fate of labeled angiotensin II microinfused into individual nephrons in the rat. (1975) (44)
Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. (2015) (44)
Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone (2001) (43)
Role of the renal nerves in the maintenance of DOCA-salt hypertension in the rat. Influence on the renal vasculature and sodium excretion. (1983) (43)
Atrial natriuretic peptide in acute hypoxia-induced pulmonary hypertension in rats. (1991) (43)
Effects of pH and enzyme inhibitors on apparent generation of angiotensin I in human plasma. (1974) (43)
Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT. (2016) (43)
Importance of the renal nerves in the pathogenesis of experimental hypertension. (1982) (43)
Mortality and Morbidity During and After the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (2012) (43)
Impaired Reflex Response to Volume Expansion in NaCl‐Sensitive Spontaneously Hypertensive Rats (1989) (42)
Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan – amlodipine combination (2008) (42)
Fibroblast growth factor mediates hypoxia-induced endothelin-- a receptor expression in lung artery smooth muscle cells. (2003) (42)
Atrial natriuretic peptide-dependent modulation of hypoxia-induced pulmonary vascular remodeling. (2006) (41)
Effect of Acute Hypoxia on the Pulmonary Conversion of Angiotensin I to Angiotensin II in Dogs (1980) (41)
Impaired Release of Atrial Natriuretic Factor in NaCl‐Loaded Spontaneously Hypertensive Rats (1988) (41)
Hypothalamic microinjection of alpha 2-adrenoceptor agonists causes greater sympathoinhibition in spontaneously hypertensive rats on high NaCl diets. (1988) (41)
Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain: the SPRINT Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study (2018) (40)
Mithramycin inhibits myointimal proliferation after balloon injury of the rat carotid artery in vivo. (1994) (40)
C-Reactive Protein-Mediated Vascular Injury Requires Complement (2010) (40)
ASH position paper: dietary approaches to lower blood pressure. (2010) (40)
Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blocker. (1998) (40)
Marked Regional Left Ventricular Heterogeneity in Hypertensive Left Ventricular Hypertrophy Patients: A Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Cardiovascular Magnetic Resonance and Echocardiographic Substudy (2008) (40)
Atrial natriuretic peptide lowers pulmonary arterial pressure in hypoxia-adapted rats. (1988) (40)
Bradykinin in the heart: friend or foe? (1999) (39)
Chronic Hypertension in Pregnancy. (2019) (39)
An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial. (2015) (39)
Intensive vs Standard Blood Pressure Control in Adults 80 Years or Older: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial (2019) (39)
Altered angiotensin I conversion in pulmonary disease. (1976) (39)
Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat. (1984) (39)
Effects of locally formed angiotensin II on renal hemodynamics. (1986) (39)
Combination therapy in hypertension. (2010) (39)
Selective downregulation of ANP-clearance-receptor gene expression in lung of rats adapted to hypoxia. (1995) (39)
Body Build and Risk of Cardiovascular Events in Hypertension and Left Ventricular Hypertrophy: The LIFE (Losartan Intervention For Endpoint reduction in hypertension) Study (2005) (38)
The effect of antihypertensive drugs on the fetus (2002) (38)
Racial differences in the pathogenesis of hypertension. (1995) (38)
Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension (2016) (38)
Estrogen Treatment Abrogates Neointima Formation in Human C-Reactive Protein Transgenic Mice (2005) (38)
Transforming growth factor-&bgr; inhibits myocardial PPAR&ggr; expression in pressure overload-induced cardiac fibrosis and remodeling in mice (2011) (38)
Aldosterone excess and resistance to 24-h blood pressure control (2007) (37)
Vasopressin lowers pulmonary artery pressure in hypoxic rats by releasing atrial natriuretic peptide. (1989) (37)
Exacerbation of Hypertension by High Chloride, Moderate Sodium Diet in the Salt‐Sensitive Spontaneously Hypertensive Rat (1987) (37)
The role of endothelin-1 in human hypertension. (2007) (37)
Epicardial Adipose Tissue and Cardiovascular Disease (2019) (37)
Converting-enzyme inhibitors increase converting-enzyme mRNA and activity in endothelial cells. (1992) (37)
The Effects of Losartan Compared to Atenolol on Stroke in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy. The LIFE Study (2005) (37)
Dietary salt reduction in hypertension--what is the evidence and why is it still controversial? (1999) (36)
Hemodynamic effects of arginine vasopressin in rats adapted to chronic hypoxia. (1989) (36)
Pulse Pressure and Effects of Losartan or Atenolol in Patients With Hypertension and Left Ventricular Hypertrophy (2005) (36)
24‐Hour Efficacy and Safety of Triple‐Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: The TRINITY Ambulatory Blood Pressure Substudy (2011) (36)
Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators. (1998) (36)
The J-curve phenomenon revisited again: SPRINT outcomes favor target systolic blood pressure below 120 mmHg (2016) (36)
Immunoreactive bradykinin and [des-Arg9]-bradykinin in low-renin essential hypertension--before and after treatment with enalapril (MK 421). (1983) (36)
cGMP inhibits TGF-beta signaling by sequestering Smad3 with cytosolic beta2-tubulin in pulmonary artery smooth muscle cells. (2011) (35)
Intrarenal angiotensin I conversion at normal and reduced renal blood flow in the dog. (1983) (35)
Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries. (2014) (35)
Estrogen and Cardiovascular Disease: Is Timing Everything? (2015) (35)
Aliskiren and valsartan in stage 2 hypertension: subgroup analysis of a randomized, double-blind study (2008) (34)
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study (2009) (34)
Concordance Between Blood Pressure in the Systolic Blood Pressure Intervention Trial and in Routine Clinical Practice. (2020) (34)
Improved quality of life in patients with generalized cardiovascular metabolic disease on a prepared diet. (1996) (34)
Nitric oxide mediates immune dysfunction in the spontaneously hypertensive rat. (1993) (33)
The use of ambulatory blood pressure monitoring among Medicare beneficiaries in 2007-2010. (2014) (33)
Obesity and Pulmonary Hypertension (2018) (33)
Hypoxia stimulates human preproendothelin-1 promoter activity in transgenic mice. (1997) (33)
Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial (2020) (33)
On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension (2017) (33)
Sex Differences in Hypertension and Stroke Risk in the REGARDS Study. (2019) (33)
Within‐Visit Variability of Blood Pressure and All‐Cause and Cardiovascular Mortality Among US Adults (2012) (32)
Pulsology rediscovered: commentary on the Conduit Artery Function Evaluation (CAFE) study. (2006) (32)
Kidney function and sodium handling in the pregnant spontaneously hypertensive rat. (1983) (32)
Long‐Term Follow‐Up of Moderately Hypercholesterolemic Hypertensive Patients Following Randomization to Pravastatin vs Usual Care: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT‐LLT) (2013) (32)
Mechanism of Renal Handling of Angiotensin II in the Dog (1973) (32)
Prevention, Diagnosis, and Management of Hypertensive Disorders of Pregnancy: a Comparison of International Guidelines (2020) (32)
Prevention of Hypertension in the SH Rat: Effects of Differential Central Catecholamine Depletion 1 (1975) (31)
Clinical significance of serum angiotensin-converting enzyme levels in sarcoidosis. (1979) (31)
Inhibiting C-Reactive Protein for the Treatment of Cardiovascular Disease: Promising Evidence from Rodent Models (2014) (31)
Altered angiotensin-converting enzyme in lung and extrapulmonary tissues of hypoxia-adapted rats. (1988) (31)
Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension. (1997) (31)
Anterior Hypothalamic Norepinephrine, Atrial Natriuretic Peptide, and Hypertension (1996) (31)
Subgroup Analyses of an Efficacy and Safety Study of Concomitant Administration of Amlodipine Besylate and Olmesartan Medoxomil: Evaluation by Baseline Hypertension Stage and Prior Antihypertensive Medication Use (2009) (31)
The First Year of Hypertension (1980) (31)
Genetic Variation in Angiotensin-Converting Enzyme Does Not Prevent Development of Cardiac Hypertrophy or Upregulation of Angiotensin II in Response to Aortocaval Fistula (2001) (30)
High NaCl Diet Enhances Arterial Baroreceptor Reflex in NaCl‐Sensitive Spontaneously Hypertensive Rats (1991) (30)
2013 European Society of Hypertension/European Society of Cardiology Hypertension Guidelines (2013) (30)
Randomized Study of Antihypertensive Efficacy and Safety of Combination Aliskiren/Valsartan vs Valsartan Monotherapy in Hypertensive Participants With Type 2 Diabetes Mellitus (2013) (30)
Mortality and Morbidity During and After Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: Results by Sex (2013) (30)
Endothelial Cells Overexpressing Interleukin-8 Receptors Reduce Inflammatory and Neointimal Responses to Arterial Injury (2012) (30)
Tyrosine kinase receptor activation inhibits NPR-C in lung arterial smooth muscle cells. (2001) (30)
Dual inhibition of the renin system by aliskiren and valsartan (2007) (30)
Blood pressure and metabolic responses to moderate sodium restriction in isradipine-treated hypertensive patients. (1997) (30)
Efficacy and safety of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in study participants with hypertension and diabetes: a subpopulation analysis of the TRINITY study. (2012) (30)
Sex Hormones and the Vasculature (1996) (29)
Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation (2021) (29)
Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study (2004) (29)
Mechanism of postarrhythmic renal vasoconstriction in the anesthetized dog. (1979) (29)
Visceral Adipose Tissue Accumulation and Residual Cardiovascular Risk (2018) (29)
Angiotensin Receptor Blocker and Dihydropyridine Calcium Channel Blocker Combinations: An Emerging Strategy in Hypertension Therapy (2009) (29)
Purification and assay methods for angiotensin-converting enzyme. (1996) (29)
The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study. (2005) (29)
Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy (2014) (29)
Antihypertensive therapy--efficacy and quality of life. (1993) (29)
Impaired pulmonary conversion of angiotensin I to angiotensin II in rats exposed to chronic hypoxia. (1986) (28)
Mechanism of Angiotensin I Converting Enzyme Inhibition by SQ20,881 ( (1979) (28)
Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients. (2012) (28)
Health Outcomes Associated with Calcium Antagonists (2001) (28)
Coarctation induces alterations in basement membranes in the cardiovascular system. (1993) (28)
Enalapril in low‐renin essential hypertension (1983) (28)
Simplified method for quantitation of angiotensin peptides in tissue. (1993) (27)
Failure of renal denervation to attenuate hypertension in Dahl NaCl-sensitive rats. (1987) (27)
Results of an Olmesartan Medoxomil–Based Treatment Regimen in Hypertensive Patients (2008) (27)
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study (2009) (27)
Long-term efficacy of a combination of amlodipine and olmesartan medoxomil±hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial (2010) (27)
Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack. (2015) (27)
Changes in cardiovascular risk associated with phentermine and topiramate extended-release in participants with comorbidities and a body mass index ≥27 kg/m(2). (2013) (27)
Muscle sympathetic nervous system activity in Black and Caucasian hypertensive subjects (1994) (27)
Arthur C. Corcoran Memorial Lecture. Hormones and vasoprotection. (1999) (27)
Proteoglycans and hypertension. I. A biochemical and ultrastructural study of aorta glycosaminoglycans in spontaneously hypertensive rats. (1986) (27)
The relationship between renal impairment and left ventricular structure, function, and ventricular–arterial interaction in hypertension (2011) (26)
Blockade of endogenous anterior hypothalamic atrial natriuretic peptide with monoclonal antibody lowers blood pressure in spontaneously hypertensive rats. (1990) (26)
Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project (2020) (26)
Essential hypertension in women (2004) (26)
Gallium 67 citrate scanning and serum angiotensin converting enzyme levels in sarcoidosis. (1982) (26)
Transforming growth factor-β regulates endothelin-1 signaling in the newborn mouse lung during hypoxia exposure. (2012) (26)
Handling of angiotensin II and oxytocin by renal tubular segments perfused in vitro. (1977) (26)
Report of workshop on lymphangioleiomyomatosis (1999) (25)
The impact of serum uric acid on cardiovascular outcomes in the LIFE study. (2004) (25)
Hypertensive crisis since FDR--a partial victory. (1995) (25)
Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension. (2001) (25)
When and how to use self (home) and ambulatory blood pressure monitoring. (2010) (25)
Long‐Term Efficacy and Safety of Triple‐Combination Therapy With Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide for Hypertension (2012) (25)
Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events (2020) (25)
High NaCl diet increases anterior hypothalamic α 2-adrenoceptors in SHR (1988) (25)
O-Linked &bgr;-N-Acetylglucosamine Modification of A20 Enhances the Inhibition of NF-&kgr;B (Nuclear Factor-&kgr;B) Activation and Elicits Vascular Protection After Acute Endoluminal Arterial Injury (2018) (25)
Central mechanisms of hypertension. (1989) (25)
Renin inhibition: should it supplant ACE inhibitors and ARBS in high risk patients? (2008) (25)
Hypertension in the elderly. (2009) (25)
Out-of-Clinic Sympathetic Activity Is Increased in Patients With Masked Uncontrolled Hypertension (2019) (25)
The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood PressureNovelty and Significance (2016) (24)
The Transcription Factor ETS-1 Mediates Proinflammatory Responses and Neointima Formation in Carotid Artery Endoluminal Vascular Injury (2010) (24)
Genetic basis of NaCl-sensitive hypertension. (1988) (24)
Angiotensin extraction by trout tissues in vivo and metabolism by the perfused gill. (1986) (24)
Refractory Hypertension Is not Attributable to Intravascular Fluid Retention as Determined by Intracardiac Volumes (2018) (24)
Mechanism of the depressor action of LY171555, a selective dopamine D2 receptor agonist, in the anesthetized rat. (1986) (24)
Oral contraceptive pill hypertension. (1975) (24)
Changes in cerebrospinal fluid Na+ concentration do not underlie hypertensive responses to dietary NaCl in spontaneously hypertensive rats (1990) (24)
The role of the posterior hypothalamic area in the pathogenesis of hypertension in the spontaneously hypertensive rat (1984) (24)
Spontaneously hypertensive rat: lymphoid depression is age dependent and mediated via a mononuclear cell subpopulation. (1992) (24)
Mineralocorticoids in normal pregnancy. (1976) (23)
Hypertrophy in the denervated heart: a comparison of central sympatholytic treatment with 6-hydroxydopamine and peripheral sympathectomy with nerve growth factor antiserum. (1979) (23)
Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target? A Protagonist View From the SPRINT Trial (Systolic Blood Pressure Intervention Trial). (2016) (23)
Genetic Basis of NaCI‐Sensitive Hypertension (1988) (23)
Elevated catecholamines during cardiac surgery: Consequences of reperfusion of the postarrested heart (1984) (23)
Endothelin-1 Mediates Hypoxia-Induced Increases in Vascular Collagen in the Newborn Mouse Lung (2007) (23)
Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEART. (2019) (23)
Endothelial cells overexpressing IL-8 receptor reduce cardiac remodeling and dysfunction following myocardial infarction. (2013) (23)
Blood Pressure and NaCl-Sensitive Hypertension Are Influenced by Angiotensin-Converting Enzyme Gene Expression in Transgenic Mice (2002) (23)
Antihypertensive Treatment in Postmenopausal Women: Results from a Prospective, Randomized, Double-Blind, Controlled Study Comparing an ACE Inhibitor (Moexipril) with a Diuretic (Hydrochlorothiazide) (1998) (23)
Central Effects of Prostaglandin E2 on Blood Pressure and Plasma Renin Activity in Rats Role of the Sympathoadrenal System and Vasopressin (1982) (23)
A randomized comparison of crystalloid and blood-containing cardioplegic solutions in 60 patients. (1984) (22)
Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy (2007) (22)
Altered stores of atrial natriuretic peptide in specific brain nuclei of NaCl-sensitive spontaneously hypertensive rats. (1991) (22)
Dietary salt supplementation selectively downregulates NPR-C receptor expression in kidney independently of ANP. (2002) (22)
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. (2007) (22)
Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats. (1987) (22)
Theoretical approaches to estimation of plasma renin activity: a review and some original observations. (1976) (22)
Prevention of Microalbuminuria in Patients With Type 2 Diabetes: What Do We Know? (2010) (22)
White-Coat Effect Is Uncommon in Patients With Refractory Hypertension (2017) (22)
Clinical experience with transdermal clonidine in African-American and Hispanic-American patients with hypertension: evaluation from a 12-week prospective, open-label clinical trial in community-based clinics. (1999) (22)
Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension from the Systolic Blood Pressure Intervention Trial (2017) (22)
NMR observation of altered sodium interaction with human erythrocyte membranes of essential hypertensives. (1980) (21)
The Story of the Silent Killer (2020) (21)
Vasorelaxing effects of estetrol in rat arteries. (2012) (21)
Refractory HypertensionNovelty and Significance (2015) (21)
Metabolite ligands of estrogen receptor-beta reduce primate coronary hyperreactivity. (2006) (21)
Differential expression of angiotensin-converting enzyme and chymase in dogs with chronic mitral regurgitation. (1999) (21)
Ambulatory Blood Pressure Monitoring in Individuals with HIV: A Systematic Review and Meta-Analysis (2016) (21)
Atrial natriuretic peptide lowers pulmonary arterial pressure in patients with high altitude disease. (1989) (21)
Differences between renal tubular processing of glucagon and insulin. (1982) (21)
Atrial natriuretic peptide regulation of noradrenaline release in the anterior hypothalamic area of spontaneously hypertensive rats. (1996) (21)
The calcium antagonists in the 1990s. An overview. (1991) (21)
Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study. (2012) (20)
Losartan benefits over atenolol in non‐smoking hypertensive patients with left ventricular hypertrophy: The LIFE study (2004) (20)
EPLERENONE PREVENTS ADVERSE CARDIAC REMODELLING INDUCED BY PRESSURE OVERLOAD IN ATRIAL NATRIURETIC PEPTIDE‐NULL MICE (2006) (20)
Dietary Ca2+ prevents NaCl-sensitive hypertension in spontaneously hypertensive rats via sympatholytic and renal effects. (1991) (20)
Antihypertensive Effect of Enalapril in Essential Hypertension: Role of Prostacyclin (1987) (20)
Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial. (2020) (20)
Atrial natriuretic peptide clearance receptor agonist lowers pulmonary pressure in hypoxic rats. (1990) (20)
Long-term morbidity and mortality trials with amlodipine. (1999) (20)
Triple-Combination Therapy with Olmesartan, Amlodipine, and Hydrochlorothiazide in Black and Non-Black Study Participants with Hypertension (2012) (20)
studies of plasma bradykininases using radiolabelled substrates. (1974) (20)
Dietary Ca2+ prevents NaCl-induced exacerbation of hypertension and increases hypothalamic norepinephrine turnover in spontaneously hypertensive rats. (1989) (20)
Ethnicity and Blood Pressure (2005) (20)
Atrial Natriuretic Factor in Central Cardiovascular Control (1993) (19)
Endothelin-A Receptor Blockade in Porcine Pulmonary Hypertension (2002) (19)
Mechanisms and Treatment of Resistant Hypertension (2008) (19)
Increased Noradrenaline Content of Hypothalamic Nuclei in Association with Worsening of Hypertension after High Sodium Intake in the Young Spontaneously Hypertensive Rat (1982) (19)
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial (2022) (19)
The role of exercise in the reversal of IGF-1 deficiencies in microvascular rarefaction and hypertension (2019) (19)
Hypertension: A New Journal (1979) (19)
Treatment of hypertension in patients with diabetes--an update. (2009) (18)
The neointimal response to endovascular injury is increased in obese Zucker rats (2003) (18)
Renal Catecholamines and α2-Adrenergic Receptors in Salt-Related and Genetic Hypertension (1987) (18)
Acute hypertension increases norepinephrine release in the anterior hypothalamic area. (1995) (18)
Reversibility of left ventricular mechanical dysfunction in patients with hypertensive heart disease (2014) (18)
Interleukin-2 does not attenuate hypertension in spontaneously hypertensive rats. (1990) (18)
Co-administration of an ACE-inhibitor (moexipril) and hormonal replacement therapy in postmenopausal women (1999) (18)
Hypertension in postmenopausal women: pathophysiology and management. (1995) (18)
Inhibition of proximal tubular hydrolysis and reabsorption of bradykinin by peptides. (1976) (18)
Hypertensive therapy: Part I. (2004) (18)
Treatment of isolated systolic hypertension in diabetes mellitus type 2 (2006) (18)
Intrahypothalamic Clonidine Infusion Prevents NaCl‐Sensitive Hypertension (1991) (18)
Renal Nerve Contribution to NaCl‐Exacerbated Hypertension in Spontaneously Hypertensive Rats (1989) (17)
Comparative antihypertensive efficacy of olmesartan: comparison with other angiotensin II receptor antagonists (2002) (17)
Decreased norepinephrine release in anterior hypothalamus of NaCl-sensitive spontaneously hypertensive rats during high NaCl intake (1991) (17)
Effect of central administration of MK-422 (the diacid form of enalapril) on the development of hypertension in the spontaneously hypertensive rat. (1984) (17)
Lofexidine and clonidine in moderate essential hypertension (1981) (17)
Effects of acute and chronic blockade of neutral endopeptidase with Sch 34826 on NaCl-sensitive hypertension in spontaneously hypertensive rats. (1992) (17)
Eprosartan versus enalapril in hypertensive patients with angiotensin-converting enzyme inhibitor-induced cough (1999) (17)
Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial (2016) (17)
Pathophysiology of sudden coronary death in women. Implications for prevention. (1998) (17)
Olmesartan/Amlodipine/Hydrochlorothiazide in Obese Participants With Hypertension: A TRINITY Subanalysis (2013) (17)
Are there meaningful differences in blood pressure control with current antihypertensive agents? (2002) (17)
Advanced Glycation End-Product Cross-Link Breakers (2004) (17)
Reverse-phase separation and electrochemical detection of neuropeptides (1985) (17)
Report of the National Heart, Lung, and Blood Institute Working Group on Hypertension: Barriers to Translation. (2020) (17)
Acute saline infusion decreases norepinephrine release in the anterior hypothalamic area. (1996) (16)
Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension. (1999) (16)
Effects of dietary salt on angiotensin peptides in kidney. (1995) (16)
Efficacy of an Olmesartan Medoxomil–Based Treatment Algorithm in Patients Stratified by Age, Race, or Sex (2010) (16)
Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT. (2014) (16)
Number of Measurements Needed to Obtain a Reliable Estimate of Home Blood Pressure: Results From the Improving the Detection of Hypertension Study (2018) (16)
Ovarian hormones and vascular disease (2013) (16)
Effect of Serum Urate Lowering With Allopurinol on Blood Pressure in Young Adults: A Randomized, Controlled, Crossover Trial (2021) (16)
Race‐based and sex‐based differences in bioactive lipid mediators after myocardial infarction (2020) (16)
Hypoxia-induced inhibition of converting enzyme activity: role in vascular regulation. (1987) (16)
Antihypertensive Medication Classes Used among Medicare Beneficiaries Initiating Treatment in 2007–2010 (2014) (16)
Review of therapeutic modalities acting directly via central pathways. (1982) (16)
Substrate Requirements for Angiotensin I Conversion In Vivo and In Vitro (1973) (16)
The role of ambulatory blood pressure monitoring compared with clinic and home blood pressure measures in evaluating moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy (2011) (16)
Lesions of the anterior hypothalamic area increase arterial pressure in NaCl-sensitive spontaneously hypertensive rats. (1990) (16)
Proceedings from Duke resistant hypertension think tank. (2014) (16)
Targeted Delivery of Pulmonary Arterial Endothelial Cells Overexpressing Interleukin-8 Receptors Attenuates Monocrotaline-Induced Pulmonary Vascular Remodeling (2014) (15)
2-Tetradecylglycidic acid, an inhibitor of carnitine palmitoyltransferase-1, induces myocardial hypertrophy via the AT1 receptor. (1999) (15)
Urinary sodium excretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone status (2016) (15)
Scientists' statement regarding data on the sodium-hypertension relationship and sodium health claims on food labeling. (1997) (15)
High blood pressure in women. (1997) (15)
Effect of hypoxia on the conversion of angiotensin I to II in the isolated perfused rat lung. (1982) (15)
Plasma angiotensin converting enzyme activity in mother and fetus. (1978) (15)
New 2017 American Heart Association and American College of Cardiology guideline for hypertension in the adults: major paradigm shifts, but will they help to fight against the hypertension disease burden? (2018) (15)
Risk stratification of sudden cardiac death in hypertension. (2017) (15)
Yohimbine-induced alterations of monoamine metabolism in the spontaneously hypertensive rat of the okamoto strain (SHR) II. The Central Nervous System (CNS) (1987) (15)
Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial. (2014) (15)
Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: the Losartan Intervention For End point reduction in hypertension (LIFE) study. (2009) (15)
Central serotonergic alterations in deoxycorticosterone acetate/NaCl (DOCA/NaCl)-induced hypertension (1988) (15)
Effect of peripheral sympathectomy on left ventricular ultrastructure in young spontaneously hypertensive rats. (1978) (14)
Excitatory sympathetic reflex in NaCl-sensitive spontaneously hypertensive rats. (1993) (14)
Treating multiple-risk hypertensive populations. (1999) (14)
Effects of sodium intake and Goldblatt hypertension on renin release in rat kidney slices. (1981) (14)
Effect of sleeve gastrectomy on hypertension. (2018) (14)
Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers (2020) (14)
Etiology and pathogenesis of systemic hypertension (2009) (14)
PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT. (2018) (14)
Prognostic value of myocardial perfusion imaging performed pre-renal transplantation: post-transplantation follow-up and outcomes (2018) (14)
Correlations of plasma renin activity and aldosterone concentration with ambulatory blood pressure responses to nebivolol and valsartan, alone and in combination, in hypertension. (2015) (14)
Dietary Ca2+ prevents NaCl-sensitive hypertension in spontaneously hypertensive rats by a sympatholytic mechanism. (1990) (14)
A simple method for determining the free cortisol index in plasma: measurements in human pregnancy. (1979) (14)
Transport and hydrolysis of glucagon in the proximal nephron. (1986) (14)
Antihypertensive Medication Adherence and Confirmation of True Refractory Hypertension (2019) (14)
&agr;2A-Adrenergic Receptors Mediate Sympathoinhibitory Responses to Atrial Natriuretic Peptide in the Mouse Anterior Hypothalamic Nucleus (2003) (14)
Targeted delivery of human iPS-ECs overexpressing IL-8 receptors inhibits neointimal and inflammatory responses to vascular injury in the rat. (2016) (14)
Vascular effects of kinins in trout and bradykinin metabolism by perfused gill. (1990) (14)
Comprehensive nutrition plan improves cardiovascular risk factors in essential hypertension. (1998) (14)
Gender and cardiovascular disease recent insights. (1997) (14)
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial (2022) (14)
Atrial Natriuretic Factor in NaCl‐Sensitive and NaCl‐Resistant Spontaneously Hypertensive Rats (1989) (14)
Sustained blood pressure control and coronary heart disease, stroke, heart failure, and mortality: An observational analysis of ALLHAT (2019) (14)
The Neuronal Basis of Salt Sensitivity (1989) (14)
Role of anterior hypothalamic angiotensin II in the pathogenesis of salt sensitive hypertension in the spontaneously hypertensive rat. (1994) (14)
Neuronal angiotensin-converting enzyme (ACE) gene expression is increased by converting enzyme inhibitors (CEI) (1991) (13)
Circadian variations in blood pressure and their implications for the administration of antihypertensive drugs: is dosing in the evening better than in the morning? (2020) (13)
Have the Renin-Angiotensin-Aldosterone System Perturbations in Cardiovascular Disease Been Exhausted? (2010) (13)
Diastolic dysfunction and heart failure with preserved ejection fraction: rationale for RAAS antagonist/CCB combination therapy. (2009) (13)
In vivo and in vitro conversion of des-1-Asp angiotensin I to angiotensin III. (1978) (13)
Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence. (2019) (13)
Central catecholamine depletion, vasopressin, and blood pressure in the DOCA/NaCl rat. (1983) (13)
Dietary Ca2+ supplementation prevents the exaggerated responsiveness of anterior hypothalamic alpha 2-adrenoceptors in NaCl-loaded spontaneously hypertensive rats. (1989) (12)
Atrial natriuretic peptide modulates baroreceptor reflex in spontaneously hypertensive rat. (1992) (12)
Missing Verification of Source Data in Hypertension Research (2021) (12)
Relation of renal hemodynamics to metabolism of angiotensin II by the canine kidney. (1977) (12)
Triple-combination treatment with olmesartan medoxomil/amlodipine/ hydrochlorothiazide in Hispanic/Latino patients with hypertension: the TRINITY study. (2014) (12)
Prevention of Heart Failure in Hypertension—Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study (2019) (12)
Sex difference in blood pressure of spontaneously hypertensive rats influenced by perinatal NaCl exposure (1992) (12)
Reserpine Substantially Lowers Blood Pressure in Patients with Refractory Hypertension: A Proof of Concept Study. (2020) (12)
Structural Requirements for Substrates and Inhibitors of Angiotensin I‐Converting Enzyme In Vivo and In Vitro (1974) (12)
Plasma xanthine oxidase activity is related to increased sodium and left ventricular hypertrophy in resistant hypertension. (2019) (12)
Primary Aldosteronism: A Practical Approach to Diagnosis and Treatment (2001) (12)
Pulse wave velocity and central aortic pressure in systolic blood pressure intervention trial participants (2018) (12)
2013 Canadian Hypertension Education Program Recommendations (2013) (12)
[Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials]. (2000) (12)
Atrial natriuretic peptide blunts arterial baroreflex in spontaneously hypertensive rats. (1996) (12)
Decrease in sympathetic nervous system activity and attenuation in response to stress following renal denervation in the one-kidney one-clip Goldblatt hypertensive rat. (1982) (12)
The Global Burden of Disease Study 2015 and Blood Pressure (2017) (12)
Enhanced Depressor Effect of Muscimol in the DOCA/NaCl Hypertensive Rat: Evidence for Altered GABAergic Activity in Brain 1 (1985) (12)
Genetic and salt-related alterations in monoamine neurotransmitters in Dahl salt-sensitive and salt-resistant rats. (1986) (11)
Secondary Prevention of Coronary Heart Disease in Women: A Call to Action (2003) (11)
Hormonal and haemodynamic responses to upper abdominal surgery during isoflurane and balanced anaesthesia (1984) (11)
Elevated catecholamines during cardiac surgery: consequences of reperfusion of the postarrested heart. (1985) (11)
Obesity, Hypertension, and Bariatric Surgery (2020) (11)
Sodium and mineralocorticoids in normal and abnormal pregnancy. (1977) (11)
Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. (2016) (11)
Sex difference in fluid exchange during food deprivation in the rabbit. (1966) (11)
The INTERSTROKE Study: hypertension is by far the most important modifiable risk factor for stroke (2017) (11)
No role for NO in estrogen-mediated vasoprotection? (1997) (11)
Atrial natriuretic peptide inhibits sympathetic outflow in NaCl-sensitive spontaneously hypertensive rats. (1991) (11)
Effect of steric exclusion on the separation of proteins by hydrophilic size-exclusion chromatography. (1988) (11)
Hormone replacement therapy and stroke: are the results surprising? (2001) (11)
H29: Comparison of the efficacy of two angiotensin II antagonists, valsartan and losartan, in essential hypertension (1997) (11)
Distinctive Risk Factors and Phenotype of Younger Patients With Resistant Hypertension: Age Is Relevant (2017) (11)
EXCEED: Exforge®-intensive control of hypertension to evaluate efficacy in diastolic dysfunction: study rationale, design, and participant characteristics (2009) (11)
Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease (2019) (11)
Moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy (2011) (10)
The Matrikine Acetylated Proline-Glycine-Proline Couples Vascular Inflammation and Acute Cardiac Rejection (2017) (10)
Captopril and the Response to Stress in the Spontaneously Hypertensive Rat (1988) (10)
Cardiovascular care for older adults: hypertension and stroke in the older adult (2016) (10)
Regression of Left Ventricular Mass After Bariatric Surgery (2017) (10)
Hypertension in 2010: New challenges in blood pressure goals and assessment (2011) (10)
Disregard the reported data from the HYGIA project: blood pressure medication not to be routinely dosed at bedtime. (2020) (10)
Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat. (1985) (10)
Angiotensin II Metabolism by Tissues from Developing Rats (1981) (10)
E101: Candesartan cilexetil enhances blood pressure reduction in severe (stage 3, JNC-VI) hypertensive patients inadequately controlled with HCTZ (1998) (10)
Quantitation of hypothalamic atrial natriuretic peptide messenger RNA in hypertensive rats. (1992) (10)
Effects of Sex Steroids in Vascular Injury (1998) (10)
Association between chronic kidney disease and cancer mortality: A report from the ALLHAT. (2017) (9)
Targeting the renin–angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (2005) (9)
Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial) (2018) (9)
Mechanism for renal tubular handling of angiotensin. (1979) (9)
Comparison of the Antihypertensive Efficacy of Irbesartan//HCTZ and Valsartan//HCTZ Combination Therapy: Impact of Age and Gender (2010) (9)
Treating Hypertension in the Elderly—Whom to Treat, When, and with What? (2001) (9)
Weight Reduction for Obesity-Induced Heart Failure with Preserved Ejection Fraction (2020) (9)
Obesity-Associated Hypertension: the Upcoming Phenotype in African-American Women (2017) (9)
Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension (2017) (9)
Race and sex differences in ambulatory blood pressure measures among HIV+ adults. (2017) (9)
Cicletanine Blunts the Pulmonary Pressor Response to Acute Hypoxia in Rats (1992) (9)
Effect of hypoxia on the conversion of angiotensin I to II in cultured porcine pulmonary endothelial cells. (1983) (9)
Catecholamines, blood pressure, renin and myocardial function in the spontaneously hypertensive rat. (1976) (9)
The organum vasculosum of the lamina terminalis regulates noradrenaline release in the anterior hypothalamic nucleus (2000) (9)
The J-curve phenomenon revisited (2009) (9)
Estimated GFR Variability and Risk of Cardiovascular Events and Mortality in SPRINT (Systolic Blood Pressure Intervention Trial). (2020) (9)
Enhanced cold pressor response in spontaneously hypertensive rats on high-NaCl diet. (1988) (9)
Cardiac hemodynamics and hypertrophy in nerve growth factor antiserum treated spontaneously hypertensive rats (1976) (9)
Subcellular sites of insulin hydrolysis in renal proximal tubules. (1984) (9)
Worsening of kidney function is the major mechanism of heart failure in hypertension: the ALLHAT study (2020) (9)
Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT]). (2016) (9)
Proteoglycans and Hypertension III: Aorta Proteoglycans in Dahl Salt‐Sensitive Hypertensive Rats (1987) (9)
Digitalis assay and its clinical application. (1976) (9)
COMMENTARY Hypertension in Women (1999) (8)
Antihypertensive effects of mibefradil in the treatment of mild-to-moderate systemic hypertension. (1997) (8)
Hypertension and Sympathetic Nervous System Activity (2004) (8)
Atrial natriuretic peptide dose dependently inhibits cardiac remodeling after exposure to pressure overload (2004) (8)
Masked Uncontrolled Hypertension Is Accompanied by Increased Out-of-Clinic Aldosterone Secretion. (2020) (8)
BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out? (2016) (8)
Hyperoxia-induced converting enzyme insufficiency in conscious rat: cardiovascular effects. (1987) (8)
Incidence and Outcomes of Acute Heart Failure With Preserved Versus Reduced Ejection Fraction in SPRINT (2021) (8)
Challenges in oscillometric blood pressure measurement in atrial fibrillation: looking for practical solutions (2018) (8)
Long term efficacy, safety, and tolerability of candesartan cilexetil added to hydrochlorothiazide in patients with severe systemic hypertension (1999) (8)
The expanding role of calcium antagonists in cardiovascular disease (1997) (7)
Effects of constituent amino acids on tubular handling of microinfused angiotensin II. (1978) (7)
Garlic prevents hypoxic pulmonary hypertension in rats. (1998) (7)
Heart Failure Prevention in Older Patients Using Intensive Blood Pressure Reduction: Potential Role of Diuretics. (2019) (7)
Enhanced response to the inhibitory action of LY171555, a dopamine D2-agonist, on in vivo striatal dopamine release in DOCA/NaCl-hypertensive rats (1987) (7)
New data on antihypertensive drugs and risk of cancer: should we worry? (2019) (7)
What do international guidelines say about therapy? (2001) (7)
Hypertension and oral contraceptives. (1981) (7)
Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroups. (2011) (7)
Safety and Tolerability of Fixed-Dose Irbesartan/Hydrochlorothiazide for Rapid Control of Severe Hypertension (2009) (7)
Angiotensin-converting enzyme in serum and in bronchoalveolar lavage in sarcoidosis. (1982) (7)
Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering? (2008) (7)
Renal Sympathetic Denervation for Treatment of Hypertension (2012) (7)
Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical Trial. (2022) (7)
Coffee and Arterial Hypertension (2021) (7)
Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report (2020) (7)
Hemodynamic Response to Vascular Expansion Following Immunosympathectomy in Spontaneously Hypertensive Rats (1980) (7)
Novel Medical Treatments for Hypertension and Related Comorbidities (2018) (7)
A simple method for concentration of biogenic amines and their metabolites from biological samples for analysis by HPLC-EC. (1989) (7)
Desoxycorticosterone in normal pregnancy. II. Cortisol-dependent fluctuations in free plasma desoxycorticosterone. (1979) (7)
Smad3-mSin3A-HDAC1 Complex is Required for TGF-β1-Induced Transcriptional Inhibition of PPARγ in Mouse Cardiac Fibroblasts (2016) (7)
Renal function during reflexly activated catecholamine flow through an adrenorenal rete. (1981) (7)
SPS3 Evidence Supports Intensive Blood Pressure Control. (2016) (7)
Spironolactone Reduces Aortic Stiffness in Patients With Resistant Hypertension Independent of Blood Pressure Change. (2021) (7)
Updated Guidelines for Management of High Blood Pressure in Japan (2014) (7)
Left-superior-vena-cava steal syndrome. (1972) (7)
Chapter 70 – Oral Contraceptives, Hormone Replacement Therapy, and Hypertension (2007) (7)
High-performance liquid chromatographic determination of amiloride and its analogues in rat plasma. (1990) (7)
Renal denervation in treatment-resistant hypertension – Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials (2014) (7)
Assessment of vascular function in low socioeconomic status preschool children: a pilot study. (2017) (7)
Blood pressure lowering effect of renal sympathetic denervation or placebo? - building expectations for Symplicity-HTN 3 (2013) (7)
Novel strategies for treatment of resistant hypertension (2013) (6)
New‐Onset Diabetes in Treated Hypertensive Patients‐Is It Clinically Significant? (2005) (6)
Hypoxia-induced oxygen tolerance: maintenance of endothelial metabolic function. (1988) (6)
Proposed Changes for NIH's Center for Scientific Review (1999) (6)
Cuff-less measurements of blood pressure: are we ready for a change? (2021) (6)
The effects of urate lowering therapy on inflammation, endothelial function, and blood pressure (SURPHER) study design and rationale. (2016) (6)
Migrating Populations and Health: Risk Factors for Cardiovascular Disease and Metabolic Syndrome (2022) (6)
Combining RAAS and calcium channel blockade: ACCOMPLISH in perspective (2008) (6)
Cardiovascular health at the crossroads: outlook for the 21st century. Presented at the 67th Scientific Sessions of the American Heart Association November 4, 1994 Dallas, Texas. (1995) (6)
Continuous intravenous infusion of LY171555, a potent selective D2 receptor agonist, lowers blood pressure in the conscious rat. (1987) (6)
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors. (2009) (6)
The elusive role of atrial natriuretic peptide in hypertension. (1995) (6)
Dietary Ca2+ increases natriuretic and diuretic responses to volume loading in NaCl-sensitive spontaneously hypertensive rats. (1990) (6)
Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: the Survey of PatIents with treatment ResIstant hyperTension study. (2019) (6)
Hormone therapy of premature ovarian failure: the case for "natural" estrogen. (2009) (6)
Hypertension in women. (2000) (6)
Angiotensin receptor - neprilysin inhibiton (ARNI) – A novel therapeutic concept for management of hypertension and heart failure (2012) (6)
Impact of the SPRINT Trial on Hypertension Management. (2018) (6)
Sex Hormones and Vascular Function (2012) (6)
Risk of Hospitalized Gastrointestinal Bleeding in Persons Randomized to Diuretic, ACE‐Inhibitor, or Calcium‐Channel Blocker in ALLHAT (2013) (6)
Role of the Dissolution Mechanism in Determining Chromatographic Separation of Biogenic Amines from Their Precursors and Metabolites by HPLC-EC (1987) (6)
Induced Pluripotent Stem Cell‐Derived Endothelial Cells Overexpressing Interleukin‐8 Receptors A/B and/or C‐C Chemokine Receptors 2/5 Inhibit Vascular Injury Response (2017) (6)
Preparative isolation of angiotensin-converting enzyme from human lung. (1992) (6)
Rapid Communication: Arginine Vasopressin Lowers Pulmonary Arterial Pressure in Rats Adapted to Chronic Hypoxia (1987) (6)
Evaluation, and Treatment of High Blood Pressure Seventh Report of the Joint National Committee on Prevention, Detection, (2008) (6)
Salt supplementation does not alter the pressor effect of blocking atrial natriuretic peptide in nucleus tractus solitarii. (1992) (6)
Antihypertensive effect of cicletanine is exaggerated in NaCl-sensitive hypertension. (1991) (6)
High NaCl diet increases anterior hypothalamic alpha 2-adrenoceptors in SHR. (1988) (5)
Mibefradil, a T-channel-selective calcium antagonist: clinical trials in hypertension. (1998) (5)
Long‐term efficacy and tolerability of azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide in chronic kidney disease (2018) (5)
Management of the hypertensive patient with coronary artery disease. (1999) (5)
Renin in differential diagnosis of hypertension. (1971) (5)
Guidelines for managing high blood pressure--reply. (2014) (5)
Tissue Angiotensin Converting Enzyme (1996) (5)
Treating the older hypertensive patient—an overview (1988) (5)
Forty-Year Shifting Distribution of Systolic Blood Pressure With Population Hypertension Treatment and Control (2020) (5)
A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension. (2008) (5)
Hyperresponsiveness of monoaminergic mechanisms in DOCA/NaCl hypertensive rats. (1985) (5)
J Curve in Hypertension (2012) (5)
The use of complementary peptides in the purification of an angiotensin II binding protein (1988) (5)
11-Beta Dehydrogenase Type 2 Activity Is Not Reduced in Treatment Resistant Hypertension (2017) (5)
Sprinting Toward the Optimal Blood Pressure Target for Hypertensive Patients. (2018) (5)
New ESH/ESC Guidelines Signal Progress in Hypertension Management (2007) (5)
Blood Pressure Goal Attainment: Meeting the Challenge of the JNC 7's Blood Pressure Goals and the Role of Renin‐Angiotensin‐Aldosterone System Blockade (2004) (5)
`Complementary peptides': a response. (1989) (5)
Will we ever use angiotensin receptor neprilysin inhibition (ARNi) for the treatment of hypertension? (2019) (5)
Racial Differences in Blood Pressure Control Following Stroke (2021) (5)
Blood pressure and migration (2010) (5)
Reduction of blood pressure in patients with treatment-resistant hypertension (2009) (5)
Systolic blood pressure control prevents cognitive decline and slows development of white matter lesions in the brain: the SPRINT MIND study outcomes (2019) (5)
One year of antihypertensive treatment in patients with LVH: the life study. (1999) (5)
Altered responsiveness of regional brain dopamine and DOPAC levels to systemic administration of quinpirole, a dopamine D2 agonist, in DOCA/NaCl-hypertensive rats (1987) (5)
Increased vasopressinergic activity following DOCA administration in the rat (1986) (5)
Should we treat prehypertension? (2009) (5)
Vascular injury induces expression of periostin: A novel vascular extracellular matrix protein via the P13-kinase-MAP kinase pathway (2003) (5)
Is there a new treatment for hypertensive disease in the horizon? Role of soluble guanylate cyclase. (2006) (4)
Blood pressure intervention and control in the systolic blood pressure intervention trial (SPRINT) (2016) (4)
Arterial stiffness and kidney disease progression in the systolic blood pressure intervention trial (2020) (4)
A stunning day in hypertension research – Results of ONTARGET, ACCOMPLISH and HYVET (2008) (4)
Regional Heterogeneity in 3D Myocardial Shortening in Hypertensive Left Ventricular Hypertrophy: A Cardiovascular CMR Tagging Substudy to the Life Study (2015) (4)
Cardiovascular Risk Reduction in Women (1996) (4)
Beta‐blockers as sub‐optimal treatment for hypertension: Time for first‐line therapy revision? (2006) (4)
Physician acceptance of computer recommended antihypertensive therapy. (1975) (4)
NaCl does not affect hypothalamic noradrenergic input in deoxycorticosterone acetate/NaCl and Dahl salt-sensitive rats. (1990) (4)
Nomenclature for experimental renovascular hypertension. Report of the Nomenclature Committee of the Council for High Blood Pressure Research of the American Heart Association. (1979) (4)
The role of atrial natriuretic peptide and endothelin in hypoxia induced pulmonary hypertension. (1994) (4)
The renin-angiotensin system in mother and fetus at cesarean section: a preliminary communication. (1976) (4)
Hypoxia stimulates human preproendothelin-1 promoter activity in transgenic mice. (1997) (4)
What is the first choice for blood pressure treatment? (2019) (4)
Chapter 2 – Pathogenesis of Hypertension (2013) (4)
Association of Sustained Blood Pressure Control with Multimorbidity Progression Among Older Adults (2020) (4)
An evaluation of the efficacy of olmesartan medoxomil in Black patients with hypertension. (2009) (4)
EDITORIALHypertension and cardiovascular disease: Is arterial stiffness the heart of the matter? (2007) (4)
Dietary NaCl loading enhances antihypertensive effect of guanabenz in spontaneously hypertensive rats. (1989) (4)
AHA / ACC / ASH Scientific Statement Treatment of Hypertension in Patients With Coronary Artery Disease (2015) (4)
P-145: Comparison of ascending doses of olmesartan medoxomil (O), losartan potassium (L) and valsartan (V) in patients (PTS) with essential hypertension (HTN) (2005) (4)
Renal denervation achieved by endovascular delivery of ultrasound in RADIANCE-HTN SOLO or by radiofrequency energy in SPYRAL HTN-OFF and SPYRAL-ON lowers blood pressure (2018) (4)
Two renal alpha 2-adrenergic receptor sites revealed by p-aminoclonidine binding. (1987) (4)
Preventing heart attack and death in patients with coronary disease. Endorsed by the board of trustees of the American College of Cardiology. (1996) (4)
812-4 Serum uric acid and ischemic stroke risk among hypertensive patients with left ventricular hypertrophy: The losartan intervention for endpoint reduction in hypertension (LIFE) study (2004) (4)
Chlorthalidone versus hydrochlorothiazide in hypertension treatment: do we have the evidence to decide? (2014) (4)
Antiplatelet Therapy for Transient Ischemic Attack (2012) (4)
Glucosamine Inhibits TNF-{alpha}-Induced Expression of Inflammatory Mediators In Rat Aortic Smooth Muscle Cells through Inhibition of NF{kappa}B Activation (2008) (4)
Hormone replacement therapy and hypertension (2002) (4)
Oral-contraceptive-induced hypertension after adrenalectomy and hypophysectomy. (1976) (4)
Chapter 3 – Pathophysiology of Hypertension (2007) (4)
Baseline Quality of Life and Risk of Stroke in the ALLHAT Study (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial) (2017) (4)
E094 The addition of candesartan cilexetil to HCTZ enhances blood pressure reduction in black patients with severe (stage 3, JNC-VI) hypertension (1998) (4)
Renal nerve ablation: Emerging role in therapeutics (2011) (4)
ALLHAT and calcium channel blockers. ALLHAT Research Group. (1997) (3)
Effects of progesterone on volume homeostasis in man: alterations in intrarenal sodium reabsorption aldosterone excretion and renin activity. (1974) (3)
CARDIOVASCULAR COMPLICATIONS IN RELATION TO THE FRAMINGHAM RISK SCORE AND AGE IN HYPERTENSIVE PATIENTS WITH LVH: THE LIFE STUDY (2000) (3)
What Is or What Is Not a Risk Factor for Arterial Hypertension? Not Hamlet, but Medical Students Answer That Question (2022) (3)
Efficacy of perindopril in the treatment of systemic hypertension. (2001) (3)
Abstract 184: Sex Differences in the Effect of Hypertension on Stroke Risk in the REasons for Geographic and Racial Differences in Stroke Study (2018) (3)
Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke (2007) (3)
Lower Blood Pressure Thresholds Raise the Bar in Pregnancy. (2019) (3)
Hypertension Management by Practice Guidelines (2014) (3)
Induced Pluripotent Stem Cell-Derived Endothelial Cells Attenuate Lipopolysaccharide-Induced Acute Lung Injury. (2019) (3)
SPRINT Revisited: Updated Results and Implications. (2021) (3)
Age and the effectiveness of anti-hypertensive therapy on improvement in diastolic function (2014) (3)
SY 11-3 HYPERTENSION IN WOMEN: MORE DANGEROUS THAN IN MEN? (2016) (3)
Improving outcomes for women after coronary artery bypass grafting: a case for prevention. (2003) (3)
The International Society of Hypertension Guidelines 2020 – a new drug treatment recommendation in the wrong direction? (2020) (3)
TCT-405 SYMPLICITY HTN-3: Outcomes in the African-American and non-African American Populations (2014) (3)
Using web‐based training to improve accuracy of blood pressure measurement among health care professionals: A randomized trial (2022) (3)
Urgent need to address quality control issues of out‐of‐office blood pressure measurement and patient risk assessment (2008) (3)
Comparison of the SCOPE and LIFE results. (2003) (3)
The ASCOT blood pressure lowering trial. (2006) (3)
Behçet’ Disease (‘Silk Route Disease’) and Mitral Valve Prolapse (1998) (3)
The five RADIANCE-HTN and SPYRAL-HTN randomised studies suggest that the BP lowering effect of RDN corresponds to the effect of one antihypertensive drug (2021) (3)
The polypill: an emerging treatment alternative for secondary prevention of cardiovascular disease (2016) (3)
Hypertension research into the new millennium (2010) (3)
SUFENTANIL INFUSION ANESTHESIA IN PATIENTS UNDERGOING VALVULAR HEART SURGERY (1985) (3)
CHAPTER 4 – Humoral Control of the Circulation (1990) (3)
Sexual Dimorphism in Cardiovascular Disease (1999) (3)
Yohimbine-induced alterations of monoamine metabolism in the spontaneously hypertensive rat. I. The peripheral nervous system (1987) (3)
Chronic infusion of atrial natriuretic peptide prevents pulmonary hypertension in hypoxia-adapted rats. (1988) (3)
Abstract 14875: Estrogen-Induced Vasoprotection is Preserved After Prolonged Estrogen Deprivation (2014) (3)
Cardiovascular Disease Risk Reduction and Body Mass Index (2022) (3)
Rationale for the use of multiple blockers of the renin–angiotensin–aldosterone system in specific patient populations (2011) (3)
Spironolactone improves blood pressure and left ventricular hypertrophy in patients with resistant hypertension (2007) (3)
Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes (2010) (3)
Direct Estrogen Effects on the Cardiovascular System (2002) (3)
Chapter 86 – Fixed Low-Dose Antihypertensive Therapy (2007) (3)
Ganglion atrial natriuretic peptide in NaCl sensitive spontaneously hypertensive rats. (1992) (2)
The PARAGON Heart Failure trial – ongoing investigation of the angiotensin receptor antagonist/neprilysin inhibitor sacubitril/valsartan in heart failure patients with hypertension and preserved ejection fraction (2019) (2)
The association of BP with cardiovascular outcomes in patients with dipstick proteinuria and preserved kidney function (2023) (2)
123I-mIBG scintigraphy: Clinical tool for assessing renal sympathetic activity? (2017) (2)
Progression to Severe Chronic Hypertension 5–7 Years After a Pregnancy With Mild Chronic Hypertension (2022) (2)
Latest News in Hypertension Management (2)
A major paradigm shift. (2007) (2)
Hypertension in a 74-year-old man with hydronephrosis and coronary disease. (1985) (2)
The ALLHAT Study Revisited: Do Newer Data From This Trial and Others Indicate Changes in Treatment Guidelines? (2007) (2)
Chapter 34 – Treatment of Hypertension in the Patient with Cardiovascular Disease* (2007) (2)
IMPACT OF OBESITY ON REVERSIBILITY OF CONTRACTILE DYSFUNCTION IN PATIENTS WITH HYPERTENSIVE HEART DISEASE (2012) (2)
Masked Hypertension (2017) (2)
Rapid Communication: Exaggerated Depressor Response to 6-lodoamiloride in NaCl-Sensitive Spontaneously Hypertensive Rats (1988) (2)
Antihypertensive drug therapy in the third millennium: Are there benefits beyond blood pressure? (2000) (2)
D023: Comparison of eprosartan and enalapril on incidence of cough in hypertensive patients with history of ace inhibitor-induced cough (1998) (2)
P-610: Ovarian hormones modulate the inflammatory response to vascular injury (2003) (2)
Treatment strategies for comorbid conditions lower residual risk in patients with treated hypertension: FOURIER and other randomized outcome trials (2017) (2)
A16 – Sexual dimorphism in NaCl sensitivity of blood pressure in the spontaneously hypertensive rat (1995) (2)
Depressive Symptoms and Incident Hospitalization for Heart Failure: Findings From the REGARDS Study (2022) (2)
Hypertension and cardiovascular risk (2013) (2)
Sites and Mechanisms of the Conversion of Angiotensin I to II (1972) (2)
TREATMENT OF HYPERTENSIVE CRISIS. AUTHORS' REPLY (1991) (2)
Untreated Hypertension and Subsequent Incidence of Colorectal Cancer: Analysis of a Nationwide Epidemiological Database (2021) (2)
Sodium–Proton (Na+/H+) Exchange Inhibition Increases Blood Pressure in Spontaneously Hypertensive Rat (1994) (2)
ONTARGET, TRANSCEND and PROFESS – Clarifying, confusing or misleading (2009) (2)
IN THE LITERATURE Efficacy and Safety of Combined Use of Aliskiren and Valsartan in Patients With Hypertension (2008) (2)
Two renal. cap alpha. /sub 2/-adrenergic receptor sites revealed by of-aminoclonidine binding (1987) (2)
SY 11-3 HYPERTENSION IN WOMEN: MORE DANGEROUS THAN IN MEN? (2016) (2)
Blood pressure variability: Emerging role in risk assessment and therapeutics (2010) (2)
What is the most appropriate target SBP in persons with hypertension and diabetes mellitus? (2018) (2)
Renin Inhibitors in the Management of Hypertension (2007) (2)
Take a Blood Pressure Pill or Benefit from Renal Denervation? (2018) (2)
Association of Sustained Blood Pressure Control with Lower Risk for High-Cost Multimorbidities Among Medicare Beneficiaries in ALLHAT (2021) (2)
Factors associated with not having a healthcare visit in the past year among US adults with hypertension: Data from NHANES 2013-2018. (2021) (2)
Antihypertensive therapy and cancer risks? (2011) (2)
B018: Age-dependent event rate and reduction of coronary risk in hypertensive patients with LVH: The life study (2000) (2)
A 42-year-old man with hypertension. (1997) (2)
82 - Targeted Delivery of Rat Aortic Endothelial Cells (RAECs) Overexpressing Interleukin-8 (IL8)Receptors Inhibits Neointimal and Inflammatory Responses to Endoluminal Injury of Carotid Artery and Acute Pulmonary Hypertension (PAH) in Rats (2014) (2)
Was it optimal to drop a diuretic as a first-line choice of drug treatment in the 2020 International Society of Hypertension Guidelines? (2020) (2)
Maintaining Normal Blood Pressure Across the Life Course (2021) (2)
Achieving better blood pressure control (2008) (2)
Tolerability profile of tasosartan, a long-acting angiotensin II AT1 receptor blocker, in the treatment of patients with essential hypertension (1997) (2)
Age‐Dependent Relationship of Hypertension Subtypes With Incident Heart Failure (2022) (2)
Angiotensin receptor blockers and cancer – Relationship dismissed by VALUE data while waiting for EMA and FDA reports (2010) (2)
Thiazide-Induced Dysglycemia (2008) (2)
Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations. (1997) (2)
Conflicting and Confusing Data From the Hypertension Treatment Trials: Whom and What Should You Believe? (2005) (2)
Can Catheter-Based Renal Denervation Be Used Safely and Effectively to Substantially Reduce Blood Pressure in Treatment-Resistant Hypertensive Patients? (2011) (2)
776 BLOOD PRESSURE MEASUREMENT DEVICE, NUMBER AND TIMING OF VISITS, AND INTRA-INDIVIDUAL STANDARD DEVIATION OF BLOOD PRESSURE (2012) (2)
197 AGING-RELATED ACCUMULATION OF O-GLCNACYLATED PROTEINS IN THE CARDIOVASCULAR SYSTEM. (2007) (2)
An Update on Refractory Hypertension (2022) (2)
Effect of Intensive versus Standard BP Control on AKI and Subsequent Cardiovascular Outcomes and Mortality: Findings from the SPRINT EHR Study (2022) (2)
Angioedema in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) (2005) (2)
Hypertension in the Time of the COVID-19 Pandemic: New Issues and Enduring Controversies (2020) (2)
Renal denervation in hypertension: is it the end or the beginning of a SPYRAL? (2017) (2)
Obstructive sleep apnea is more severe in men but not women with refractory hypertension compared with controlled resistant hypertension (2020) (2)
Antihypertensive therapy in the era of evidence based medical practice: what to do until the facts are in. (1996) (2)
Prevalence of pseudoresistant hypertension due to blood pressure measurement technique in a hypertension specialty clinic (2016) (1)
TIME to face the reality about evening dosing of antihypertensive drugs in hypertension. (2022) (1)
Cardiology and Epidemiology and Prevention Council for High Blood Pressure Research and the Councils on Clinical Heart Disease: A Scientific Statement From the American Heart Association Treatment of Hypertension in the Prevention and Management of Ischemic (2007) (1)
OR-12: Atrial natriuretic peptide inhibits collagen production in cardiac fibroblast (2004) (1)
Conversion of Angiotensin I to II In Vivo and In Vitro (1972) (1)
Hypertension: what it is; what it isn't; how to think about it, to prevent it, and to manage it. Interview by George D. Lundberg. (2007) (1)
Visit-to-visit variability of blood pressure and coronary heart disease, stroke, heart failure and mortality: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (2014) (1)
Renal handling of glucagon and insulin. (1984) (1)
/sup 67/Ga citrate scanning and serum angiotensin converting enzyme levels in sarcoidosis (1982) (1)
OP0208 EFFECT OF SERUM URATE LOWERING WITH ALLOPURINOL ON BLOOD PRESSURE IN YOUNG ADULTS (2019) (1)
Clinical trials report (2006) (1)
SAFETY AND TOLERABILITY OF COMBINATION OLMESARTAN MEDOXOMIL (OM)+AMLODIPINE BESYLATE (AML)+HYDROCHLOROTHIAZIDE (HCTZ) IN PATIENTS WITH HYPERTENSION: THE TRINITY STUDY: PP.5.166 (2010) (1)
Proteasomal Inhibition: A Novel Pathway for Prevention of Atherosclerosis and Restenosis (2008) (1)
Abstract 657: Fc{gamma} Receptors Enable Human C-Reactive Protein to Exacerbate Neointima Formation in Transgenic Mice (2006) (1)
D7: Differential effects of calcium channel blockers on heart rate in women (1997) (1)
Sustained SBP control and long-term nursing home admission among Medicare beneficiaries (2021) (1)
A true champion of Hungarian kidney research and nephrology education--tribute to László Rosivall. (2009) (1)
Bradykinin in the Heart (1999) (1)
INTENSIVE TREATMENT WITH COMBINATION AMLODIPINE/VALSARTAN PROVIDES GREATER EFFICACY VS MODERATE TREATMENT FOR HYPERTENSIVE PATIENTS UNCONTROLLED ON ARB MONOTHERAPY: THE EXTRA STUDY: PP.5.208 (2010) (1)
Nocturnal blood pressure dipping in treated hypertensives: insights from the SPRINT trial. (2020) (1)
Prevention of hypertension in the spontaneously hypertensive rat effects of differential central catecholamine depletion (1975) (1)
Evidence-Based Guidelines for Cardiovascula r Disease Prevention in Women: 2007 Updat e (2007) (1)
CardioPulse. The SPRINT trial results. (2016) (1)
GREATER EFFICACY WITH AMLODIPINE/VALSARTAN COMBINATION INTENSIVE VS MODERATE TREATMENT FOR HYPERTENSIVE PATIENTS WITH CARDIOMETABOLIC SYNDROME UNCONTROLLED ON ARB MONOTHERAPY: PP.34.432 (2010) (1)
Does improving hypertension control involve more than just pills? (2007) (1)
Case of Episodic and Positional Hypertension: Diagnosis and Treatment. (2020) (1)
Antihypertensive therapy in the context of total cardiovascular risk: the rational basis for therapeutic recommendations. (1994) (1)
The Human Side of Failed Hypertension Treatment (2013) (1)
E080 A comparison of telmisartan with lisinopril in patients with mild to moderate hypertension (1998) (1)
Pathophysiology of hypertension Editorial overview (1993) (1)
Managing heart disease in pregnancy. (1976) (1)
P-445: CS-866 versus losartan, valsartan, and irbesartan in patients with essential hypertension (2001) (1)
Purification of angiotensin-converting enzyme by gel high-performance liquid chromatography. (1989) (1)
366 ATRIAL NATRIURETIC PEPTIDE AND CYCLIC GUANOSINE MONOPHOSPHATE BLOCK THE STIMULATORY EFFECTS OF TRANSFORMING GROWTH FACTOR β1 ON EXTRACELLULAR MATRIX MESSENGER RIBONUCLEIC ACID EXPRESSION IN CULTURED PULMONARY ARTERY SMOOTH MUSCLE CELLS (2005) (1)
The Sexual Dimorphism of Cardiovascular Disease (1997) (1)
INTENSIVE DOSE OF COMBINATION AMLODIPINE/VALSARTAN PROVIDES IMPROVED 24-H BP RESPONSE COMPARED TO MODERATE DOSE IN HYPERTENSIVE PATIENTS UNCONTROLLED ON ARB MONOTHERAPY: PP.5.211 (2010) (1)
Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure. (2021) (1)
Abstract P369: Non-Adherence to Antihypertensive Medications is Associated with Higher BP and Anxiety Levels. (2018) (1)
Outcomes of Shared IRB Compared with Multiple Individual Site IRB Models in a Multisite Clinical Trial. (2023) (1)
Initial Medication Selection For Treatment Of High Blood Pressure (1995) (1)
HOPE-3 and SPRINT: two landmark trials with different outcomes? (2016) (1)
Intensive systolic blood pressure control and prevention of new onset atrial fibrillation in the SPRINT study: is the association really controversial? (2020) (1)
Metabolism of angiotensin I by the trout gill (1985) (1)
State of the Art: the Not-So-Great Wall of America (2019) (1)
Reply to Visit‐to‐Visit Blood Pressure Variation: Time to Reanalyze All The Data From the TROPHY Study (2013) (1)
HYPERTENSION: a companion to brenner & rector's the kidney (2017) (1)
Should we prefer different drugs to treat hypertension in older and younger adults? Practical implications of clinical trials: American perspective. (2008) (1)
Heart Failure Primary Prevention: What Does SPRINT Add? (2021) (1)
Abstract 20887: Masked Uncontrolled Hypertension is Not Attributable to Medication Non-Adherence (2017) (1)
Ambulatory blood pressure results of symplicity HTN-3 trial (2014) (1)
Renal Afferent Nerves: Evidence for a Role in Cardiovascular Regulation and the Pathogenesis of Experimental Hypertension (1984) (1)
VALSARTAN PROVIDES EFFECTIVE ANTIHYPERTENSIVE RESPONSE IN OLDER PATIENTS: AN INTEGRATED ANALYSIS (2000) (1)
Blood Pressure Intervention and Control in SPRINT (2022) (1)
Blunted responsiveness of posterior hypothalamic norepinephrine to quinpirole in DOCA/NaCl hypertensive rats (1987) (1)
Evidence for marked disproportionate myocardial dysfunction in the septum in hypertensive left ventricular hypertrophy (1998) (1)
Response to Intervisit Blood Pressure Variability and Outcome: Is Heart Rate a Missing Confounder? (2011) (1)
368 THE MODULATORY EFFECT OF ATRIAL NATRIURETIC PEPTIDE ON EXTRACELLULAR PROTEIN EXPRESSION IN MICE SUBJECTED TO PRESSURE AND VOLUME OVERLOAD (2005) (1)
Anxiety and sleep as potential mechanisms underlying heightened sympathetic tone in patients with refractory hypertension (2016) (1)
Hypertension, 2nd Edition (2006) (1)
The INTERSALT Study and the complex relationship between salt intake and blood pressure (2017) (1)
Role of Oxygen in Cystic Fibrosis Transmembrane Conductance Regulator Expression and (2008) (1)
What is the association of renin–angiotensin–aldosterone system inhibitors with COVID-19 outcomes: retrospective study of racially diverse patients? (2022) (1)
Subject Index, Vol. 33, 1986 (1986) (1)
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women Expert Panel / Writing Group * (2004) (1)
Go Red for Women Estrogen and Mechanisms of Vascular Protection (2009) (1)
Blood Pressure and the Electronic Health Record: A Work in Progress (2019) (1)
Characteristics of young and old patients with resistant hypertension in a large, diverse cohort (2015) (1)
EFFICACY AND SAFETY OF COMBINATION OLMESARTAN MEDOXOMIL (OM)+AMLODIPINE BESYLATE (AML)+HYDROCHLOROTHIAZIDE (HCTZ) IN PATIENTS WITH HYPERTENSION: THE TRINITY STUDY: PP.5.177 (2010) (1)
Abstract 052: Social Determinants Of Health And Uncontrolled Blood Pressure In A National Cohort Of Black And White US Adults (2022) (1)
INTENSIVE TREATMENT WITH COMBINATION AMLODIPINE/VALSARTAN VS MODERATE THERAPY FOR HYPERTENSIVE PATIENTS WITH DIABETES OR CKD UNCONTROLLED ON ARB MONOTHERAPY: PP.17.149 (2010) (1)
An appropriate SCORE to assess cardiovascular risk in hypertension? (2011) (1)
Hyperaldosteronism causes volume overload cardiac hypertrophy in patients with resistant hypertension (2008) (1)
Chapter 28 – Initial Evaluation and Approach to the Patient with Hypertension (2013) (1)
Heart disease in pregnancy. (1973) (1)
Noninvasive Assessment of Renal Artery Stenosis by Combined Conventional and Color Doppler Ultrasound (1990) (1)
4P-1039 Rosuvastatin-induced modulation of NO-dependent superoxide formation (2003) (1)
Pet Ownership and the Risk of Arterial Hypertension and Cardiovascular Disease (2022) (1)
O-30: Predictors of cardiovascular events in 9,194 hypertensive patients with left ventricular hypertrophy. The LIFE study* (2001) (1)
Revisiting ASCOT 16 years later (2018) (1)
Reduction in blood pressure for elevated blood pressure/stage 1 hypertension according to the ACC/AHA guideline and cardiovascular outcomes. (2022) (1)
More is Less? Optimal Combination Therapy for Adequate Blood Pressure Lowering in Hypertension (2008) (1)
TRIPLE COMBINATION THERAPY WITH AMLODIPINE/VALSARTAN/HCTZ AT MAXIMAL DOSES IS SAFE AND EFFECTIVE FOR HYPERTENSIVE PATIENTS UNCONTROLLED ON ARB MONOTHERAPY: THE EXTRA STUDY: PP.5.216 (2010) (1)
Chapter 54 – Ischemic Heart Disease (2005) (1)
Aortic blood pressure and arterial stiffness in patients with controlled resistant and non‐resistant hypertension (2020) (1)
Fenoldopam: A novel, peripherally acting dopamine-1 agonist for parenteral treatment of hypertension (1997) (1)
Impact of intensive blood pressure therapy on patient-perceived health status: results from the sprint study (2016) (1)
The State of Hypertension Guidelines: 2012 (2012) (0)
278 IMPAIRED VENTRICULAR FUNCTION AND INCREASED CARDIAC COLLAGEN IN ATRIAL NATRIURETIC PEPTIDE-NULL MICE EXPOSED TO PRESSURE OVERLOAD. (2004) (0)
CARDIAC HYPERTROPHY IN YOUNG SPONTANEOUSLY HYPERTENSIVE RATS BEFORE THE ONSET OF HYPERTENSION (1977) (0)
Morphologie substrates of sudden death: Questions and answers (1985) (0)
Ovarian hormones modulate neointima formation in an animal vascular injury model through effects on neutrophil chemokine production (2004) (0)
The PARAGON-Heart failure trial – another disappointment for heart failure patients with hypertension and preserved ejection fraction (2019) (0)
Abstract 4888: Parallel Improvement In Central And Peripheral Pulse Pressure And Plasma Natriuretic Peptide In Hypertension With Diastolic Dysfunction: Exceed Trial Investigators (2008) (0)
Treatment Intensity, Prescribing Patterns, and Blood Pressure Control in Rural Black Patients with Uncontrolled Hypertension. (2022) (0)
Social Determinants of Health and Uncontrolled Blood Pressure in a National Cohort of Black and White US Adults: the REGARDS Study. (2023) (0)
Epidemiology of hypertension (2012) (0)
Hypertensive Therapy: Part II trials Review: Clinical Cardiology: New Frontiers (2004) (0)
Abstract 59: Social Determinants of Health and Incident Apparent Treatment Resistant Hypertension in a National Cohort of Black and White US Adults (2023) (0)
Abstract 4428: Similar Response to Spironolactone in Whites and African American Patients with Resistant Hypertension (2008) (0)
Case of Refractory Hypertension Controlled After Aortic and Mitral Valve Replacement and Coronary Artery Bypass Grafting. (2018) (0)
The Effects of Thiazides Plus Calcium Channel Blockers-Reply (1990) (0)
Reasons for Uncontrolled Blood Pressure Among US Adults: Data From the US National Health and Nutrition Examination Survey (2021) (0)
166 GLYCOSYLATED C-REACTIVE PROTEIN STIMULATES PROINFLAMMATORY MEDIATOR EXPRESSION IN RAT AORTIC SMOOTH MUSCLE CELLS. (2006) (0)
235: Effects of Aldosterone Receptor Blockers in Resistant Hypertension and Stage III Chronic Kidney Disease (2010) (0)
New Lessons in Hypertension and Diabetes: An Update on Clinical Trials and Clinical Guidelines (2012) (0)
Renin–angiotensin–aldosterone inhibitors in combination therapy (2012) (0)
1 Sex Hormones and Vascular Function (2017) (0)
Abstract 14845: Targeted Delivery of Endothelial Cells Overexpressing Interleukin-8 Receptors Attenuates Ischemia-Reperfusion Acute Kidney Injury (2014) (0)
Critical aspects in hypertension diagnosis and treatment (2009) (0)
Hypertension. Introduction. (2001) (0)
Abstract 17889: Estrogen Effects on Vascular Inflammation are Age-Dependent (2012) (0)
Estrogen reduces neointima formation independent of INOS expression in mouse carotid ligation model of vascular injury (2002) (0)
SPIRONOLACTONE DOES NOT CHANGE 24HR BP CIRCADIAN PATTERN IN RESISTANT HYPERTENSIVE PATIENTS (2019) (0)
White Coat Hypertension???Fact or Fancy? (1996) (0)
Angiotensin II formation from angiotensin converting enzyme and chymase-like enzyme in the normal human heart and in hearts from various mammals (1996) (0)
365 ADVERSE CARDIAC REMODELING AND FIBROSIS INDUCED BY PRESSURE OVERLOAD IS PREVENTED BY EPLERENONE IN ATRIAL NATRIURETIC PEPTIDE NULL MICE (2005) (0)
High dietary salt worsens aldosterone-induced proteinuria in patients with resistant hypertension (2007) (0)
Chapter 31 – The LIFE Study (2005) (0)
AN UNEXPECTED CAUSE OF ATRIAL FIBRILLATION (2023) (0)
Proceedings of the Sixth Meeting of the International Society of Hypertension, Göteborg, Sweden, 11-13 June 1979. (1979) (0)
Abstract 5415: Improvement in Diastolic Function With Anti-Hypertensive Therapy: An Analysis From the Combined VALIDD-EXCEED Dataset (2009) (0)
Similar response to spironolactone in Whites and African-American patients with resistant hypertension (2008) (0)
Similar prevalence of hyperaldosteronism in African American and White subjects with resistant hypertension (2008) (0)
Estrogen receptor expression and anti-inflammatory function is diminished in post-menopausal women and restored with menopausal hormone therapy (2015) (0)
Levels of 24-h urinary sodium predict blood pressure response to spironolactone in uncontrolled resistant hypertensive patients independent of aldosterone status (2015) (0)
Abstract 17015: Increased Protein O-GlcNAcylation Inhibits TNF-α-Induced NFkB Signaling in Rat Aortic Smooth Muscle Cells (2010) (0)
Abstract 5124: Renal Function and Cardiac Structure and Function in Hypertensives With Established Diastolic Dysfunction in the VALIDD and EXCEED Trials (2009) (0)
High dietary sodium blunts effects of mineralocorticoid receptor antagonism on left ventricular hypertrophy regression in patients with resistant hypertension (2016) (0)
Inhibition of neointimal formation by targeted delivery of porcine coronary arterial endothelial cells overexpressing interleukin-8 (IL8) receptors in pig coronary arteries after stent implantation (2015) (0)
The Health Outcomes Prevention and Evaluation 4 (HOPE 4) project: A successful community-based intervention to lower cardiovascular risk in people with hypertension (2020) (0)
Abstract P221: Cardiovascular Outcomes In Hypertensive Patients Who Discontinue Study Medication In A Large Outcome Trial. The Life Study. (2022) (0)
Purification of an Angiotensin II Receptor (1990) (0)
Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension. (2023) (0)
Response to should more significance be granted to medication response to antihypertensives in patients with resistant hypertension? (2014) (0)
Race and muscle sympathetic nerve reactivity to mental and physical stress. (1995) (0)
169 EFFECTS OF ESTROGEN AND AGING ON INTRACELLULAR O-GLYCOSYLATION (O-GlcNAc) IN THE VASCULATURE. (2006) (0)
S-16-1: RESISTANT HYPERTENISION: CLINICAL CHARACTERISTICS AND BLOOD PRESSURE CONTROL (2023) (0)
Comprehensive drug management of hypertension. (1984) (0)
Abstract 16558: Endothelial Cell Transfusion Protects Against Chronic Kidney Disease-Induced Endothelial Dysfunction in Nephrectomized Rats (2011) (0)
Hypertension and Cardiovascular Disease Risk Among Individuals With Versus Without HIV (2023) (0)
Research Article Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries (2014) (0)
33 ATRIAL NATRIURETIC PEPTIDE INHIBITS COLLAGEN PRODUCTION IN CARDIAC FIBROBLASTS. (2004) (0)
49 ESTROGEN MODULATES NEUTROPHIL CHEMOTAXIS ACTIVITY OF RAT AORTIC SMOOTH MUSCLE CELLS TREATED WITH TUMOR NECROSIS FACTOR α (2005) (0)
Clinical Trials Report (2002) (0)
Treatment of early hypertension among persons living with HIV in Haiti: Protocol for a randomized controlled trial. (2021) (0)
AGE RELATED DIFFERENCES IN ANGIOTENSIN II (A-II) METABOLISM IN RAT TISSUES (1980) (0)
Hypertension: Initial evaluation (1996) (0)
Abstract 1219: Counterregulatory Roles of TGF-{beta} and ANP Signaling in Pressure Overload-Induced Cardiac Remodeling and Fibrosis (2007) (0)
Abstract W P172: Baseline Quality of Life and Risk of Stroke in the Antihypertensive and Lipid Lowering to Prevent Heart Attack (ALLHAT) Trial (2015) (0)
Glucosamine inhibits acute inflammatory mediator expression and neointima formation in balloon‐injured rat carotid artery (2007) (0)
118 IMPAIRED VENTRICULAR FUNCTION AND INCREASED CARDIAC COLLAGEN IN ATRIAL NATRIURETIC PEPTIDE-NULL MICE EXPOSED TO PRESSURE OVERLOAD. (2004) (0)
Long-term safety of fixed-dose combinations: azilsartan medoxomil/chlorthalidone (AZL-M/CLD) vs olmesartan medoxomil/hydrochlorothiazide (OLM/HCTZ) in hypertensive subjects with stage 3 chronic kidney disease (2014) (0)
HYPOTHALAMIC MICROPERFUSION OF NEUTRAL ENDOPEPTIDASE INHIBITOR REDUCES LOCAL NOREPINEPHRINE RELEASE IN SPONTANEOUSLY HYPERTENSIVE RATS (2003) (0)
Abstract P209: Antihypertensive Medication Non-Adherence is Common in Patients With Suspected Refractory Hypertension (2018) (0)
Tribute: John H. Laragh, MD. (2015) (0)
RESERPINE SUBSTANTIALLY LOWERS BLOOD PRESSURE IN PATIENTS WITH REFRACTORY HYPERTENSION, A PHENOTYPE OF ANTIHYPERTENSIVE TREATMENT FAILURE (2020) (0)
55 ESTROGEN INHIBITS TUMOR NECROSIS FACTOR α-INDUCED EXPRESSION OF INFLAMMATORY MEDIATORS IN RAT AORTIC SMOOTH MUSCLE CELLS IN VITRO (2005) (0)
Estrogenic vasoprotection is lost in aged rats (2004) (0)
cGMP Inhibits TGF- (cid:1) Signaling by Sequestering Smad3 with Cytosolic (cid:1) 2-Tubulin in Pulmonary Artery Smooth Muscle Cells (2011) (0)
LOW SODIUM INTAKE: LOW SODIUM INTAKE: CARDIOVASCULAR HEALTH CARDIOVASCULAR HEALTH BENEFIT OR RISK? BENEFIT OR RISK? (2015) (0)
Abstract P234: Obstructive Sleep Apnea is More Common in Patients With Masked Uncontrolled Hypertension (2018) (0)
176 ALDOSTERONE EXCESS IS ASSOCIATED WITH TRUE TREATMENT RESISTANCE AS INDICATED BY SUSTAINED AMBULATORY BLOOD PRESSURE LEVELS AND LESS WHITE-COAT EFFECT. (2007) (0)
Abstract P174: Incidence of Hyponatremia on Spironolactone in Patients With a Prior Episode of Chlorthalidone-Induce Hyponatremia (2019) (0)
THE SAFETY AND EFFICACY OF LOSARTAN/HYDROCHLOROTHIAZIDE IN THE TREATMENT OF PATIENTS WITH SEVERE HYPERTENSION; A MULTICENTER STUDY: P2.39 (2000) (0)
Women2011 Update: A Guideline From the American Heart Association Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in (2011) (0)
Dose-response characteristics of mibefradil, a selective T-type calcium channel blocker in the treatment of essential hypertension (1997) (0)
Renovascular hypertension in middle-aged females. (1984) (0)
Estrogen and the Vascular Injury Response (2000) (0)
Diets high in chloride but normal in sodium exacerbate hypertension in sodium chloride sensitive spontaneously hypertensive rats (1986) (0)
Connecting Generations of Scientists in the Council on Hypertension Through Harriet Dustan. (2021) (0)
AFRICAN-AMERICANS: AN INTEGRATED ANALYSIS (2000) (0)
Faculty Opinions recommendation of Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. (2007) (0)
The LIFE sudy (2005) (0)
Targeted delivery of pulmonary arterial endothelial cells overexpressing IL8RA and IL8RB receptors attenuates monocrotaline-induced pulmonary vascular remodeling and hypertension in rats (2014) (0)
Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited (2019) (0)
Benefits of hypertension management in diabetes: An opportunity not to be missed (2008) (0)
DISTRIBUTION OF SYSTOLIC BLOOD PRESSURE REDUCTIONS FROM THE TRINITY STUDY: EFFICACY OF COMBINATION OLMESARTAN MEDOXOMIL+AMLODIPINE BESYLATE+HYDROCHLOROTHIAZIDE: 7A.08 (2011) (0)
Iconographies supplémentaires de l'article : Chronic Hypertension in Pregnancy (2020) (0)
Dietary salt supplementation selectively downregulates (2001) (0)
EFFECT OF ANTI-HYPERTENSIVE THERAPY ON LEFT ATRIAL FUNCTION IN PATIENTS WITH HYPERTENSIVE HEART DISEASE (2012) (0)
NOVEL 24-HOUR BLOOD PRESSURE PROFILE IN PATIENTS WITH RESISTANT HYPERTENSION (2019) (0)
In memoriam: Peter Sleight 1929-2020. (2020) (0)
An Open Letter to ASH Members. (2007) (0)
Abstract 11666: Targeted Delivery of Rat iPS-Endothelial Cells Overexpressing Neutrophil IL8-RA/RB or Macrophage CCR2/CCR5 Receptors Inhibits Neointima Formation in Balloon Injured Rat Carotid Artery (2015) (0)
Aldosterone induces intracardiac volume overload in patients with resistant hypertension - spironolactone but not thiazide diuretics overcomes it (2008) (0)
Presentation of the Southern Society for Clinical Investigation Founder's Medal to Dr. James A. Pittman, Jr. (1993) (0)
High-salt diet and aldosterone induces vascular damage in patients with resistant hypertension (2008) (0)
Women's health, cardiovascular risk and hypertension: the perspective still needs to improve. (2023) (0)
Abstract P187: Incidence and Predictors of Diuretic-Induced Hyponatremia (2019) (0)
H40 Characteristics of the diabetic cohort in the ALLHAT study (1997) (0)
Abstract 13061: Vascular Smooth Muscle Cell-selective O-GlaNAcylation Protects Arteries Against Acute Injury (2013) (0)
The design and rationale of a multicenter real-world trial: The southeastern collaboration to improve blood pressure control in the US Black Belt - Addressing the triple threat. (2023) (0)
Abstract 4925: TGF-{beta} Downregulates PPARgamma Gene Expression in Pulmonary Arterial Smooth Muscle Cells (PASMCs): Novel Mechanism of Hypoxia-induced Pulmonary Vascular Remodeling (2009) (0)
Reimbursement for ambulatory blood pressure monitoring among medicare beneficiaries during 2007 to 2010 (2014) (0)
PS 04-23 NOVEL TARGETED ENDOTHELIAL CELL THERAPY FOR VASCULAR INJURY IN RODENT AND PORCINE MODELS (2016) (0)
ADHERENCE DECREASES WITH HIGHER NUMBER OF MEDICATIONS IN CONTROLLED HYPERTENSIVE PATIENTS, CONTROLLED RESISTANT PATIENTS HAVE LOWER ADHERENCE THAN CONTROLLED NON-RESISTANT PATIENTS (2021) (0)
Board of Directors and Membership Benefits (2008) (0)
Role of augmented aldosterone secretion in regulation of volume homeostasis in pregnancy. (1974) (0)
Thirty years with LIFE—a randomized clinical trial with more than 200 published articles on clinical aspects of left ventricular hypertrophy (2022) (0)
Wednesday, May 14, 4:00 PM-6:00 PM-Hypertension in the Obese Patient: Pathogenic Mechanisms, Cardiovascular Risk, and Treatment: Treating hypertension in the obese patient (2003) (0)
Aldosterone, Salt, and Vascular Injury: Lessons from Rodent Models with (2005) (0)
Spironolactone improves aldosterone related obstructive sleep apnea in subjects with resistant hypertension (2008) (0)
Abstract MP019: Contributors to the Black-White Disparities in Incident Hypertension (2017) (0)
Comparative effectiveness of antihypertensive medication classes on cardiovascular events and all-cause mortality among medicare beneficiaries initiating antihypertensive therapy (2015) (0)
Association of Cardiovascular Health Metrics with Risk of Transition to Hypertension in Non-Hypertensive Young Adults. (2022) (0)
Abstract 18210: Acetylated Proline-Glycine-Proline Couples Extracellular Matrix Fragmentation to Increased Vascular Endothelin-1 Production in Heart Transplant Patients (2016) (0)
Evaluating novel approaches for estimating awake and sleep blood pressure: design of the Better BP Study – a randomised, crossover trial (2022) (0)
Treatment of high blood pressure in acute stroke – The SCAST Study (2011) (0)
Original Investigation Incident ESRD and Treatment-Resistant Hypertension: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study (2014) (0)
Special Lecture (2005) (0)
Benefits of treating hypertension: the Clinical Trialists Collaboration Group (2004) (0)
178 FIBROBLAST GROWTH FACTOR UPREGULATES PERIOSTIN AND OSTEOPONTIN EXPRESSION VIA DISTINCT SIGNALING PATHWAYS IN RAT PULMONARY ARTERIAL SMOOTH MUSCLE CELLS. (2004) (0)
THE EFFECT OF RENAL FUNCTION ON INCIDENCE OF CONGESTIVE HEART FAILURE: THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART ATTACK TRIAL (ALLHAT) STUDY (2020) (0)
American Society of Hypertension, Inc Leadership Message (2006) (0)
The National Health and Nutrition Examination Survey III: How Are We Doing with Blood Pressure Control? (2000) (0)
RE Letter to the Editor: Prehypertension is associated with multiple poor maternal and fetal outcomes by Giovanni Sisti. (2019) (0)
Plasma renin activity and aldosterone levels in patients with hypertension receiving fixed-dose combination of nebivolol and valsartan: substudy of a phase 3 randomized trial (2014) (0)
Women's health—hormone replacement treatment (2004) (0)
Abstract 15037: Hyperreninemic Aldosteronism in Caucasian and African-American Patients With Apparent Resistant Hypertension (2015) (0)
Calcium antagonists: antihypertensive and vascular considerations (1995) (0)
Estrogen enhances IkBα synthesis and inhibits NF‐kB p65 binding to the promoters of inflammatory genes in rat aortic smooth muscle cells (2009) (0)
Dietary salt restriction in patients with resistant hypertension controls blood pressure and improves vascular function (2008) (0)
In memoriam: Peter Sleight 1929–2020 (2020) (0)
Better drug adherence improves blood pressure control and lowers cardiovascular disease outcomes – from single pill combinations to monitoring of a nationwide health insurance database (2021) (0)
Efficacy and tolerability of a nebivolol-valsartan single-pill combination by sex in individuals with hypertension (2015) (0)
Endothelial Cells Overexpressing CXCR1/2 are Renoprotective in Rats with Acute Kidney Injury. (2023) (0)
OS 33-02 IN PATIENTS WITH RESISTANT HYPERTENSION INCREASED 24-H URINARY CORTISOL LEVEL PREDICT INCREASED BODY MASS INDEX. (2016) (0)
ANTIHYPERTENSIVE TREATMENT FAILURE NOT ATTRIBUTABLE TO PERSISTENT INTRAVASCULAR FLUID RETENTION AS DETERMINED BY MRI-MEASURED INTRACARDIAC VOLUMES (2017) (0)
Abstract P182: Post-Discharge Ambulatory Care Follow-Up Among Medicaid Beneficiaries With Diabetes, Hospitalized for Heart Failure (2023) (0)
Activation of PPARγ by rosiglitazone inhibits pressure overload‐induced cardiac hypertrophy and improves diastolic dysfunction in mice (2011) (0)
Beyond brachial pressure effect. (2008) (0)
Clinical trials report (2008) (0)
Chlorthalidone and Hydrochlorothiazide for Treatment of Patients With Hypertension. (2020) (0)
Comparing Approaches That Clinics Can Use to Help Control High Blood Pressure among Black Patients (2023) (0)
Thomas N. James, MD, 1925–2010 (2010) (0)
Myofibroblast Differentiation in Cultured Human Dental Pulp Tissue Correlation between Fibrillin-1 Degradation and mRNA Downregulation and (2015) (0)
A7958 Prevalence and clinical characteristics of patients with treatment resistant hypertension by region: the spirit study (2018) (0)
Abstract P326: Apparent Treatment Resistant Hypertension and Risk for Stroke, Coronary Heart Disease and All-cause Mortality (2013) (0)
High mortality explained by mildly elevated blood pressure in Scandinavian adolescent conscripts – A plea for early drug treatment? (2011) (0)
Novel strategies for treatment of resistant (2013) (0)
Abstract 16371: Targeted Delivery of Pulmonary Arterial Endothelial Cells Overexpressing Interleukin-8 Receptors Attenuates Liposaccharide-induced Lung Injury (2015) (0)
418 TRANSGENIC MICE WITH TRANSFORMING GROWTH FACTOR β TYPE II RECEPTOR DYSFUNCTION HAVE ATTENUATED HYPOXIA-INDUCED PULMONARY HYPERTENSION AND REMODELING (2005) (0)
LEFT VENTRICULAR MASS AND DIASTOLIC FUNCTION ARE SIMILAR IN PATIENTS WITH CONTROLLED RESISTANT AND CONTROLLED NON-RESISTANT HYPERTENSION (2019) (0)
Drug treatment of hypertension. (1977) (0)
Recent outcome trials of newer antihypertensives (1999) (0)
Electrocardiographic Measures of Left Ventricular Hypertrophy in the Antihypertensive and Lipid-Lowering to Prevent Heart Attack Trial (2016) (0)
965-52 Relationship Between Heart Chymase and ACE Activity in Dogs with Volume Overload Hypertrophy and Increased Cardiac Angiotensin Peptide Levels (1995) (0)
17β-estradiol inhibits C-reactive protein-driven vascular inflammation in macrophages derived from young but not aged mice (2011) (0)
Abstract WMP50: A Shift in the Population Distribution of Systolic Blood Pressure as a Contributor to the Decline in Stroke Mortality (2018) (0)
S-52-1: CARDIOVASCULAR OUTCOMES IN HYPERTENSIVE PATIENTS WHO DISCONTINUE STUDY MEDICATION IN A LARGE OUTCOME TRIAL. THE LIFE STUDY. (2023) (0)
Glucosamine Inhibits TNF‐α‐Induced Expression of Inflammatory Mediators In Rat Aortic Smooth Muscle Cells through Inhibition of NFκB Activation (2008) (0)
Prevalence of white coat and masked hypertension in refractory and controlled resistant hypertensive patients (2015) (0)
Blocking Hypothalamic Al \ Receptors Lowers Blood Pressure in Salt-Sensitive Rats (2005) (0)
Cardiovascular risks in HIV patients (2010) (0)
Aldosterone excess increases left and right heart volumes in patients with resistant hypertension: Spironolactone but not thiazide diuretics overcome it (2008) (0)
Knowledge of Primary Care Patients Living in the Urban Areas about Risk Factors of Arterial Hypertension (2023) (0)
How to deal with the occurrence of rare drug-induced adverse events: the example of sprue-like enteropathy induced by olmesartan medoxomil and other angiotensin-receptor blockers (2020) (0)
practice applications LETTERS TO THE EDITOR (2010) (0)
Suzanne Oparil SPS 3 Evidence Supports Intensive Blood Pressure Control (2016) (0)
Abstract 104: Amplification of Systolic Blood Pressure and Pulse Pressure is Higher in Resistant Hypertensive Patients Irrespective of Blood Pressure Control (2019) (0)
Save the Date — Call for Abstracts (2015) (0)
Integrated Care Model of Adiposity-Related Chronic Diseases (2022) (0)
Abstract P024: Blood Pressure Levels, Aggressiveness of Antihypertensive Therapy, and Prevalence of Left Ventricular Hypertrophy (2015) (0)
Message from the President A Good Year (2007) (0)
Fibroblast growth factor upregulates periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells (2004) (0)
Sex Steroids and Hypertension (2007) (0)
smooth muscle cells endothelin-A receptor expression in lung artery Fibroblast growth factor mediates hypoxia-induced (2015) (0)
From The Lancet (1990) (0)
Abstract 17948: Endothelial Cell Infusion Improves Chronic Kidney Disease-induced Endothelial Dysfunction in 5/6 Nephrectomized Rats (2012) (0)
Abstract P317: Nocturnal Blood Pressure Variability is associated with hs-CRP in Hypertensive Patients (2018) (0)
Abstract 13606: A New Right Bundle Branch Block in Hypertensive Patients on Doxazosin Mediates Congestive Heart Failure: The ALLHAT Study (2019) (0)
ISH-PL-3: MY ROAD TO ACADEMIC CARDIOLOGY (2023) (0)
Abstract 100: Hip and Pelvic Fracture Risk in Adults Treated with Three Different Classes of Antihypertensive Medications: The ALLHAT Study (2016) (0)
P-408: Eplerenone reverses systolic dysfunction induced by pressure overload in atrial natriuretic peptide null mice (2005) (0)
Abstract 15477: Endothelial Cells Overexpressing Interleukin-8 Receptors are Renoprotective in Rats With Acute Kidney Injury (2015) (0)
Abstract 19898: Heightened Sympathetic Activity Related to Masked Uncontrolled Hypertension in Treated Hypertensive Patients (2016) (0)
Hypertension in the Young (1984) (0)
Orthostatic systolic blood pressure changes in SPRINT participants at baseline (2015) (0)
G020: Valsartan provides effective antihypertensive response in older patients: An integrated analysis (2000) (0)
Board of Directors and Membership Benefits (2010) (0)
Conference on dietary sodium and health : proceedings of a symposium held in Arlington, VA, December 15-16, 1994 (1997) (0)
Hipertension en la mujer = Hypertension in women (2010) (0)
Abstract P163: Masked Uncontrolled Hypertension in Treated Hypertensive Patients Have Heightened Out-Of-Clinic Aldosterone Levels (2019) (0)
Abstract 14994: Reversibility of Contractile Dysfunction in Patients with Hypertensive Heart Disease (2011) (0)
Effect of Intensive Versus Standard Blood Pressure Control on Stroke Subtypes (2021) (0)
Eplerenone Reverses Pressure Overload Induced Cardiac Remodeling and Failure in Atrial Natriuretic Peptide Null Mice (2006) (0)
Update on Clinical Guidelines for Treatment of Hypertension (2014) (0)
Cardiac renin angiotensin system in hypertrophy and the progression to heart failure (1996) (0)
Validation of a Remote Monitoring Blood Pressure Device in Pregnancy. (2023) (0)
Preventive cardiology abstractEfficacy and tolerability of eplerenone and losartan in hypertensive black and white patients (2003) (0)
Depressive symptoms, cognitive impairment, and all-cause mortality among REGARDS participants with heart failure (2022) (0)
170A ABSTRACTS - Cardiac Function and Heart Failure 1135-145 Preoperative Diagnosis of Diabetes Affects Long-Term Outcome In Patients After Heart Transplantation (2002) (0)
The question of whether diabetes and its cardiovascular risks can be prevented: A realistic DREAM? (2006) (0)
Featured Cover (2022) (0)
Thursday, 5/18, Mercury Ballroom, 1:30 pm–3:30 pm Theme I: Neural Mechanisms in HypertensionNatriuretic Peptides in Brain: Role in Blood Pressure (1995) (0)
Resistant hypertension characterized by hyperaldosteronism and refractory intravascular volume expansion (2007) (0)
Are current guidelines optimal for treatment of blood pressure in patients with coronary artery disease? (2007) (0)
ASH 2008: "Living the Vision". (2008) (0)
HIGH PREVALENCE OF INFLAMMATORY DISORDERS IN PATIENTS WITH REFRACTORY HYPERTENSION (2019) (0)
Global Blood Pressure Screening: A Wakeup Call. (2020) (0)
Atrial natriuretic peptide gene load modulates pressure overload-induced cardiac remodeling (2004) (0)
Abstract P273: Association Between 24-hr Urinary Cortisol and Severity of Obstructive Sleep Apnea in Patients With Resistant Hypertension (2017) (0)
Combining proteomics, home blood pressure telemonitoring and patient empowerment to improve cardiovascular and renal protection (2021) (0)
Dietary Sodium and Aldosterone Levels Are Related to Severity of Obstructive Sleep Apnea in Patients with Resistant Hypertension (2011) (0)
Primary cardiovascular prevention by Mediterranean diet – The PREDIMED trial (2013) (0)
The Anterior Hypothalamus and Salt-Sensitive Hypertension (2004) (0)
I008: Valsartan is an effective antihypertensive in both women and men: An integrated analysis (2000) (0)
Hypertension in Postmenopausal Women: Brief Review of the Literature and Future Research Directions (1994) (0)
Importance of gender and age in assessing the 24-hour blood pressure response to antihypertensive therapy (1999) (0)
Estrogen Reduces Inflammation and Alters Mitochondrial Function in Postmenopausal Women Through Modulation of Macrophage Phenotype (2015) (0)
Exaggerated depressor response to 6-iodoamiloride in NaCl-sensitive spontaneously hypertensive rats. (1988) (0)
ALDOSTERONE AND CORTISOL: IS THERE A COMMON STIMULUS IN SUBJECTS WITH RESISTANT HYPERTENSION?: 168 (2007) (0)
High dietary salt worsens urinary protein excretion in patients with aldosterone excess and resistant hypertension (2007) (0)
Documentation of endpoint prevention with combination therapy in hypertension is urgently needed (2007) (0)
217 TRANSGENIC MICE WITH TRANSFORMING GROWTH FACTOR β TYPE II RECEPTOR DYSFUNCTION HAVE ATTENUATED HYPOXIA-INDUCED PULMONARY HYPERTENSION AND REMODELING (2005) (0)
CHAPTER 28 – Hypertensive Emergencies (2010) (0)
Blood Pressure in 2016: increased impact factor and change of editors (2016) (0)
Does a 3-D strain analysis invalidate 2-D strain? observations in hypertensive left ventricular hypertrophy from the LIFE trial using magnetic resonance imaging (2003) (0)
Pressure overload in the atrial natriuretic peptide deficient mouse: a novel model of heart failure (2003) (0)
Workshop : epidemiology and classification of hypertension (1991) (0)
Fixed-dose combination of nebivolol and valsartan in patients with stage 1 or 2 hypertension: ABPM substudy of a phase 3 randomized trial (2014) (0)
Workshop Epidemiology and Classification of Hypertension: Participants (1991) (0)
Association of a Multiancestry Genome-Wide Blood Pressure Polygenic Risk Score With Adverse Cardiovascular Events (2022) (0)
LONG-TERM EFFICACY AND SAFETY OF COMBINATION OLMESARTAN MEDOXOMIL/AMLODIPINE BESYLATE+ HYDROCHLOROTHIAZIDE BASED ON HYPERTENSION SEVERITY: THE TRINITY STUDY: 7A.05 (2011) (0)
Abstract 3771: Blocking of Transforming Growth Factor (TGF)-{beta} Signaling Exacerbates Pressure Overload-induced Left Ventricular Remodeling and Dysfunction (2008) (0)
OS 24-04 A PILOT STUDY ASSESSING THE FEASIBILITY OF VASCULAR FUNCTION IN LOW SOCIOECONOMIC STATUS PRESCHOOL CHILDREN (2016) (0)
The Role of the Renal Nerves in the Pathogenesis of Hypertension* (2020) (0)
Blood pressure target in patients with hypertension and type-2 diabetes older than 65 years. Is <130/80 mmHg the right target or an excessive objective preventing from achieving the clinical goals we are aiming at? (2021) (0)
Rapid Communication Diurnal Blood Pressure Variation and Dietary Salt in Spontaneously Hypertensive Rats (2005) (0)
A histologic and histochemical study of normal and dystrophic muscle in preclinical stages in strain 129 mice. (1961) (0)
184 ESTROGEN ATTENUATES INFLAMMATORY MEDIATOR mRNA EXPRESSION IN BALLOON INJURED RAT CAROTID ARTERY. (2004) (0)
Lung MK 351A uptake after hypoxia adaptation and subsequent hyperoxia exposure. (1988) (0)
Lung MK 351A uptake after hypoxia adaptation and subsequent hyperoxia exposure (1988) (0)
Estrogen attenuates inflammatory mediator mrna expression in balloon injured rat carotid arteries (2004) (0)
119 ATRIAL NATRIURETIC PEPTIDE MODULATES EXTRACELLULAR MATRIX EXPRESSION IN PATHOLOGIC BUT NOT PHYSIOLOGIC LEFT VENTRICULAR HYPERTROPHY. (2004) (0)
Raloxifene Does Not Inhibit Neointima Formation After Balloon Injury of the Rat Carotid Artery: P-84. (1999) (0)
P-235: Blood pressure goal attainment: comparative efficacy of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan (2004) (0)
Medication Naïve Blood Pressure and Incident Cancers: Analysis of Two Nationwide Population-Based Databases. (2022) (0)
RACE/ETHNIC DIFFERENCES IN ANTIHYPERTENSIVE RESPONSE TO MODERATE VS INTENSIVE DOSE OF COMBINATION AMLODIPINE/VALSARTAN IN PATIENTS UNCONTROLLED ON ARB MONOTHERAPY: PP.5.204 (2010) (0)
cardiopulmonary bypass in man Neuronal and adrenomedullary catecholamine release in response to (2011) (0)
Regulation of cortisol (F) secretion in pregnancy. (1976) (0)
Estrogen Signaling Modulates Mitochondrial ROS Production and Mitochondrial Function in Mouse Bone Marrow Macrophages (2017) (0)
The central nervous system and salt-induced hypertension (1994) (0)
Abstract P116: Hypertension Severity As Quantified By Hypertension Daily Dose (HDD) And Blood Pressure And Risk Of Stroke In The REGARDS Study (2022) (0)
37 ATRIAL NATRIURETIC PEPTIDE MODULATES EXTRACELLULAR MATRIX EXPRESSION IN PATHOLOGIC BUT NOT PHYSIOLOGIC LEFT VENTRICULAR HYPERTROPHY. (2004) (0)
Final Farewell to Alberto Zanchetti MD. (2018) (0)
Research Article Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality (2014) (0)
Comparison of Levels of Large and Small High-Density Lipoprotein Cholesterol in Asian Indian Men Compared With Caucasian Men in the Framingham Offspring Study (2004) (0)
Abstract 92: Prevalence and Predictors of Apparent Treatment-Resistant Hypertension among Individuals with a History of Physician-Diagnosed Stroke or TIA (2014) (0)
Estrogen Attenuates Integrin- b 3 –Dependent Adventitial Fibroblast Migration After Inhibition of Osteopontin Production in Vascular Smooth Muscle Cells migration after inhibition of OPN expression in VSMCs. (2000) (0)
John H. Laragh, MD (2015) (0)
Does GISSI-AF change the concept of using RAS inhibitors in the primary prevention of atrial fibrillation in hypertensive patients? (2009) (0)
104 Reduced noradrenergic input to anterior hypothalamus underlies genetically mediated NaCl sensitivity in the spontaneously hypertensive rat (1988) (0)
LONG-TERM EFFICACY AND SAFETY OF COMBINATION OLMESARTAN MEDOXOMIL/AMLODIPINE BESYLATE+HYDROCHLOROTHIAZIDE STRATIFIED BY DIABETES STATUS AND BODY MASS INDEX: SUBGROUP ANALYSES OF THE TRINITY STUDY: 7A.06 (2011) (0)
Hypoxia upregulates expression of periostin, a novel extracellular matrix protein, in rat lung via PI3 kinase- MAP kinase signaling pathway (2003) (0)
PS 14-14 24-HOUR URINARY SODIUM PREDICTS LEFT VENTRICULAR HYPERTROPHY REGRESSION TO SPIRONOLACTONE IN PATIENTS WITH RESISTANT HYPERTENSION (2016) (0)
Estrogen Attenuates Early Carotid Artery Injury-Induced Inflammation (2004) (0)
O‐GlcNAcylation inhibits NFκB activation in rat aortic smooth muscle cells through proteasome inhibition (2009) (0)
Acknowledgments (2017) (0)
Risk Factors, Mechanisms, and Causes of Essential Hypertension (2022) (0)
Abstract 15486: Spironolactone Reduces Severity of Obstructive Sleep Apnea in Resistant Hypertension (2012) (0)
Abstract 204: Non-dipper Pattern Is Associated With Urinary Metanephrines In Patients With Refractory Hypertension (2014) (0)
Research Article Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement (2016) (0)
MASKED UNCONTROLLED HYPERTENSION IN TREATED HYPERTENSIVE PATIENTS IS NOT RELATED TO ANXIETY COMPARED TO TRUE CONTROLLED HYPERTENSION (2019) (0)
The AJMS Celebrates # 200! (2019) (0)
LONG-TERM EFFICACY AND SAFETY OF COMBINATION OLMESARTAN MEDOXOMIL/AMLODIPINE BESYLATE + HYDROCHLOROTHIAZIDE STRATIFIED BY AGE: A TRINITY STUDY SUBGROUP ANALYSIS: PP.44.422 (2011) (0)
JASH Inaugural Issue. (2007) (0)
P-145: Atrial natriuretic peptide modulates pathologic but not physiologic left ventricular hypertrophy (2003) (0)
Intensive blood pressure treatment consistently reduces heart failure events across all key subgroups in the sprint study (2016) (0)
Mechanisms of Glucosamine‐Mediated Relaxing Responses in Isolated Rat Aortic Rings (2011) (0)
Contents, Vol. 33, 1986 (1986) (0)
A good year. (2007) (0)
Fighting the NIH funding crisis. (1995) (0)
Abstract 12784: Targeted Delivery of Endothelial Cells by Overexpressing Interleukin-8 Receptors Inhibits Neointimal Responses to Vascular Injury: Novel Mechanism of Vasoprotection (2010) (0)
Chapter 30 – The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (2005) (0)
Do angiotensin receptor antagonists have benefits beyond blood pressure lowering? (2002) (0)
Glucosamine Protects Against TNFα‐Induced Endothelial Dysfunction in Cultured Rat Aortic Rings (2011) (0)
Renal catecholamines and alpha 2-adrenergic receptors in salt-related and genetic hypertension. (1987) (0)
Abstract 4853: Spironolactone Therapy is Associated With Rapid Improvements in Blood Pressure Control and Cardiac Remodeling in Patients With Resistant Hypertension (2009) (0)
INCIDENCE AND IMPLICATIONS OF ATRIAL FIBRILLATION IN HYPERTENSION: INSIGHTS FROM THE SPRINT TRIAL (2020) (0)
1059 POLYSOMNOGRAPHIC CHARACTERISTICS OF PATIENTS WITH REFRACTORY HYPERTENSION COMPARED TO CONTROLLED RESISTANT HYPERTENSION (2017) (0)
Cardiovascular Disease and Race Efficacy and Tolerability of Eplerenone and Losartan in Hypertensive Black and White Patients (2003) (0)
Shades of Opinion: What Is Prudent? (1996) (0)
Targeted delivery of endothelial cells by overexpression of interleukin-8 receptors promotes functional recovery of the kidney after ischemia-reperfusion injury (2015) (0)
Revisiting the pre-hypertension debate: Increasing evidence for treatment – or not? (2013) (0)
Ambulatory Blood Pressure Adds to Explaining Benefits of AT‐1 Receptor Blockade in the Treatment of Left Ventricular Hypertrophy (2007) (0)
Vasorelaxing Effects of Estetrol (E 4 ) in Rat (2012) (0)
The AFCR: is there life after 41? (1982) (0)
OS 33-02 IN PATIENTS WITH RESISTANT HYPERTENSION INCREASED 24-H URINARY CORTISOL LEVEL PREDICT INCREASED BODY MASS INDEX (2016) (0)
Recruitment and retention of primary care practices in the Southeastern Collaboration to Improve Blood Pressure Control (2023) (0)
ESTROGENIC VASOPROTECTION IS LOST IN AGED RATS.: 301 (2004) (0)
Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project. (2020) (0)
MPS 03-08 ON-TREATMENT BLOOD PRESSURE AND CARDIOVASCULAR OUTCOMES IN OLDER ADULTS WITH ISOLATED SYSTOLIC HYPERTENSION: VALSARTAN IN ELDERLY ISOLATED SYSTOLIC HYPERTENSION (VALISH) STUDY (2016) (0)
Lowering Albuminuria-Does It Lower the Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005. (2005) (0)
Hypertension and Its Complications in a Young Man With Autoimmune Disease. (2017) (0)
Estrogen is vasoprotective in osteopontin deficient mice (2003) (0)
Volume overload-induced cardiac remodeling is exaggerated in mice with homozygous deletion of the atrial natriuretic peptide gene (2002) (0)
P-538: Estrogen reduces neointima formation independent of osteopontin expression in mouse carotid ligation model of vascular injury (2002) (0)
G025: Valsartan provides effective antihypertensive response in African-Americans: An integrated analysis (2000) (0)
ALLHAT Revisited: How Have the Findings Held Up 5 Years Later? (2007) (0)
The role of exercise in the reversal of IGF-1 deficiencies in microvascular rarefaction and hypertension (2019) (0)
Direct renin inhibitors in hypertension – Approaching the moment of truth (2012) (0)
Abstract P048: The Association Between Apparent Treatment Resistant Hypertension and Low Mental and Physical Functioning, Depressive Symptoms, and Stress. (2014) (0)
Comprar The Brenner and Rector Family of Books | Barry M. Brenner | 9781416039822 | Saunders (2007) (0)
Plasma renin activity in hypertension. (1975) (0)
A STITCH Saves Time and Lowers Blood Pressure (2010) (0)
P-242: Antihypertensive efficacy of olmesartan medoxomil in hypertensive men compared with hypertensive women (2003) (0)
968-28 Sexual Dimorphism of Myointimal Proliferation After Balloon Injury of Rat Carotid Artery is Estrogen Dependent (1995) (0)
Classic papers symposium of the Southern Clinical Research meetings: white coat hypertension--fact or fancy? (1996) (0)
Stroke outcomes in life (2003) (0)
The evolving role of angiotensin-II receptor blockers in cardiovascular risk reduction. Case study. (1998) (0)
Response to “Comment’s on the Story of the Silent Killer, a History of Hypertension: Its Discovery, Diagnosis, Treatment, and Debate” (2021) (0)
Racial Differences in XO (Xanthine Oxidase) and Mitochondrial DNA Damage-Associated Molecular Patterns in Resistant Hypertension (2022) (0)
ME-1: ROLE OF MINERALOCORTICOID RECEPTOR BLOCKERS IN RESISTANT AND REFRACTORY HYPERTENSION (2023) (0)
Abstract 114: Sympathetic Activity Increases With Obesity in Hypertensive Patients (2017) (0)
P-314: Hypertension control rates and hypertensive subtypes in the year 2000: an analysis comparing the clinics-based path and population-based NHANES III surveys (2002) (0)
JNC7 and ALLHAT: Changes in American and European guidelines (2009) (0)
SSCI Founders Medal recipient's address. (1995) (0)
MPS 11-10 Targeted Delivery of Rat Induced Pluripotent Stem Cell-Derived Endothelial Cells Overexpressing Interleukin-8 Receptors Attenuates Liposaccharide-Induced lung Injury (2016) (0)
Lung Growth and Repair Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells (2004) (0)
Treatment of Early Hypertension among Persons Living with HIV in Haiti: protocol for a randomized controlled trial (2021) (0)
Author Response to Lipid‐Lowering in African Americans in ALLHAT—Optimism Bias? (2013) (0)
New-onset diabetes in treated hypertensive patients--is it clinically significant? Roundtable discussion. (2005) (0)
OS 24-04 A PILOT STUDY ASSESSING THE FEASIBILITY OF VASCULAR FUNCTION IN LOW SOCIOECONOMIC STATUS PRESCHOOL CHILDREN. (2016) (0)
Abstract MP69: Prevalence of Treatment Resistant Hypertension Among Individuals with Chronic Kidney Disease: Results from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study (2013) (0)
High-salt diet and aldosterone induces vascular damage and fluid retention in patients with resistant hypertension (2008) (0)
Abstract P251: Out-of-clinic Cortisol Secretion Is Increased In Masked Uncontrolled Hypertension (2021) (0)
The Matrikine Acetylated Proline-Glycine-Proline Couples Vascular Inflammation and Acute Cardiac Rejection (2017) (0)
Where are we going? Beyond JNC 7. (2007) (0)
Paradoxical effect of age on improvements in pulse pressure during blood pressure lowering (2015) (0)
301 ESTROGENIC VASOPROTECTION IS LOST IN AGED RATS. (2004) (0)
Abstract 4240: Quantitative Assessment of Left Atrial Function in Patients with Hypertension and Impaired Diastolic Function (2008) (0)
Neopterin — A Forgotten Biomarker (2016) (0)
Interview with Suzanne Oparil, MD. Interview by Marvin Moser, MD. (2004) (0)
Increased time varying heart rate and cardiovascular risk in hypertension – Benefit of selective I(f) channel inhibitor? (2012) (0)
Should antihypertensive treatment recommendation differ for patients with and without coronary heart disease? report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (2014) (0)
Glucosamine Protects Against TNF{alpha}-Induced Endothelial Dysfunction in Cultured Rat Aortic Rings (2011) (0)
Blood Pressure celebrates 20 years of dedication to Nordic hypertension research (2010) (0)
The predictors of pulse pressure independent of systolic blood pressure in resistant hypertension (2015) (0)

This paper list is powered by the following services:

Other Resources About Suzanne Oparil

en.wikipedia.org

What Schools Are Affiliated With Suzanne Oparil?

Suzanne Oparil is affiliated with the following schools:

Suzanne Oparil's Academic­Influence.com Rankings